RAMSAY HEALTH CARE INC
10-Q, 1995-11-20
HOSPITALS
Previous: PRECISION STANDARD INC, 10-Q, 1995-11-20
Next: RESIDENTIAL FUNDING MORTGAGE SECURITIES I INC, 8-K, 1995-11-20



<PAGE>
 
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-Q

(MARK ONE)
/X/            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

               FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 1995

                                       OR

/  /    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934

     For the Transition period from ____________________to_________________

                          Commission file No. 0-13849

                            RAMSAY HEALTH CARE, INC.

             (Exact name of registrant as specified in its charter)

               DELAWARE                          63-0857352
     (STATE OR OTHER JURISDICTION            (I.R.S. EMPLOYER
     OF INCORPORATION OR ORGANIZATION)    IDENTIFICATION NUMBER)

                  ONE POYDRAS PLAZA
            639 LOYOLA AVENUE, SUITE 1700
               NEW ORLEANS, LOUISIANA                     70113
     (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)           (ZIP CODE)

      Registrant's telephone number, including area code:  (504) 525-2505

     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                          Yes    X          No     
                                ---                ---

     The number of shares of the Registrant's Common Stock outstanding at
November 15, 1995 follows:

           Common Stock, par value $0.01 per share - 8,012,701 shares
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

                                   FORM 10-Q


                                     INDEX


<TABLE>
<CAPTION>
                                                                          Page
                                                                          ----
<S>                                                                         <C>
PART I.   FINANCIAL INFORMATION
Item 1. Financial Statements
 Consolidated balance sheets - September 30, 1995 and
  June 30, 1995 (unaudited)...............................................  1
 
Consolidated statements of operations - quarter ended September 30, 1995
  and 1994 (unaudited)....................................................  3
 
Consolidated statements of cash flows - quarter ended September 30, 1995
  and 1994 (unaudited)....................................................  4
 
Notes to consolidated financial statements - September 30, 1995
  (unaudited).............................................................  5
 
Item 2. Management's Discussion and Analysis of Financial Condition
and Results of Operations.................................................  8
 
PART II.  OTHER INFORMATION

Item 6. Exhibits and Current Reports on Form 8-K ......................... 13

SIGNATURES................................................................ 15
</TABLE>
<PAGE>
 
                         PART I.  FINANCIAL INFORMATION

                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

                          CONSOLIDATED BALANCE SHEETS
                                  (UNAUDITED)

<TABLE>
<CAPTION>
                                                              SEPTEMBER 30      JUNE 30
                                                                  1995           1995
                                                             -------------   ------------
<S>                                                           <C>            <C>
ASSETS
CURRENT ASSETS
 Cash and cash equivalents..................................  $  6,045,000   $ 9,044,000
 Patient accounts receivable, less allowances for doubtful
  accounts of $3,469,000 and $3,886,000 at
  September 30, 1995 and June 30, 1995, respectively........    23,705,000    21,564,000
 Amounts due from third-party contractual agencies..........     5,303,000     5,956,000
 Other receivables..........................................     3,444,000     3,655,000
 Other current assets.......................................     2,370,000     2,764,000
                                                              ------------  ------------
  TOTAL CURRENT ASSETS......................................    40,867,000    42,983,000
 
OTHER ASSETS
 Cash held in trust.........................................     1,648,000     1,778,000
 Cost in excess of net asset value of purchased businesses..       638,000       663,000
 Unamortized preopening and loan costs......................     1,895,000     2,221,000
 Receivable from affiliated company.........................     7,250,000     7,170,000
 Deferred income taxes......................................     8,932,000     8,652,000
 Other non-current assets...................................     2,218,000     2,301,000
                                                              ------------  ------------
                                                                22,581,000    22,785,000
 
 
PROPERTY AND EQUIPMENT
 Land.......................................................     5,359,000     5,383,000
 Building and improvements..................................    77,764,000    77,630,000
 Equipment, furniture and fixtures..........................    19,846,000    19,611,000
                                                              ------------  ------------
                                                               102,969,000   102,624,000
 Less accumulated depreciation..............................    30,288,000    29,156,000
                                                              ------------  ------------
                                                                72,681,000    73,468,000
                                                              ------------  ------------
                                                              $136,129,000  $139,236,000
                                                              ============  ============
</TABLE>



                See notes to consolidated financial statements.

                                       1
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

                          CONSOLIDATED BALANCE SHEETS
                                  (UNAUDITED)



<TABLE>
<CAPTION>
 
 
                                                                   SEPTEMBER 30      JUNE 30
                                                                       1995           1995
                                                                   -------------  -------------
<S>                                                                <C>            <C>
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
CURRENT LIABILITIES
 Accounts payable................................................  $  3,072,000   $  3,868,000
 Accrued salaries and wages......................................     4,077,000      4,843,000
 Other accrued liabilities.......................................     1,191,000      1,347,000
 Amounts due to third-party contractual agencies.................     5,592,000      4,996,000
 Current portion of long-term debt...............................     6,333,000      3,831,000
                                                                   ------------   ------------
  TOTAL CURRENT LIABILITIES......................................    20,265,000     18,885,000
 
LIABILITIES FOR SELF-INSURANCE CLAIMS, less
 current portion.................................................     1,224,000      1,337,000
 
LONG-TERM DEBT, less current portion.............................    52,178,000     55,568,000
 
MINORITY INTERESTS...............................................     1,075,000      1,667,000
 
STOCKHOLDERS' EQUITY
 Class B convertible preferred stock, Series C, $1 par value
  --authorized 152,321 shares; issued 142,486 shares
  (liquidation value of $7,244,000) including accrued dividends
  of $91,000.....................................................       233,000        233,000
 Common Stock, $.01 par value--authorized 20,000,000
  shares; issued 8,316,878 shares at September 30, 1995 and
  8,290,795 shares at June 30, 1995..............................        83,000         83,000
 Additional paid-in capital......................................    99,146,000     99,147,000
 Retained earnings (deficit).....................................   (34,176,000)   (33,785,000)
 Treasury Stock, at cost--581,550 shares at September 30, 1995
  and June 30, 1995..............................................    (3,899,000)    (3,899,000)
                                                                   ------------   ------------
                                                                     61,387,000     61,779,000
                                                                   ------------   ------------
 
                                                                   $136,129,000   $139,236,000
                                                                   ============   ============
 
</TABLE>



                See notes to consolidated financial statements.

                                       2
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

                     CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (UNAUDITED)



<TABLE>
<CAPTION>
 
 
                                                                               QUARTER ENDED SEPTEMBER 30
                                                                               ---------------------------
                                                                                   1995           1994
                                                                               --------------  -----------
<S>                                                                            <C>             <C>
 
NET REVENUES                                                                     $29,129,000   $35,823,000
Operating Expenses:
   Salaries, wages and benefits.................................                  16,239,000    17,734,000
   Other operating expenses.....................................                   9,556,000    11,011,000
   Provision for doubtful accounts..............................                     956,000     1,285,000
   Depreciation and amortization................................                   1,335,000     1,840,000
   Interest and other financing charges.........................                   1,726,000     2,167,000
                                                                                 -----------   -----------
        TOTAL OPERATING EXPENSES................................                  29,812,000    34,037,000
                                                                                 -----------   -----------
 
INCOME (LOSS) BEFORE MINORITY INTERESTS
   AND INCOME TAXES.............................................                    (683,000)    1,786,000
Minority interests..............................................                     (52,000)      847,000
                                                                                 -----------   -----------
INCOME (LOSS) BEFORE INCOME TAXES...............................                    (631,000)      939,000
Provision for income taxes......................................                    (240,000)      351,000
                                                                                 -----------   -----------
 
      NET INCOME (LOSS).........................................                 $  (391,000)  $   588,000
                                                                                 ===========   ===========
 
Income (loss) per common and dilutive common equivalent share:
   Primary......................................................                      $(0.06)        $0.06
   Fully diluted................................................                      $(0.06)        $0.06
 
Weighted average number of shares outstanding:
   Primary......................................................                   7,721,000     9,481,000
   Fully diluted................................................                   7,735,000     9,547,000
 
</TABLE>



                See notes to consolidated financial statements.

                                       3
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                                  (UNAUDITED)
<TABLE>
<CAPTION>
 
                                                                                QUARTER ENDED SEPTEMBER 30
                                                                                ---------------------------
                                                                                      1995          1994
                                                                               --------------  ------------
<S>                                                                              <C>           <C>
 
Cash Flows from Operating Activities
Net income (loss)...............................................                 $  (391,000)  $   588,000
Adjustments to reconcile net income (loss) to net cash used in
 operating activities:
 Depreciation and amortization..................................                   1,526,000     2,034,000
 Benefit for deferred income taxes..............................                    (280,000)      (53,000)
 Provision for doubtful accounts................................                     956,000     1,285,000
 Minority interests.............................................                     (52,000)      847,000
 Cash flows from (increase) decrease in operating assets:
  Accounts receivable...........................................                  (3,097,000)     (513,000)
  Amounts due from third-party contractual agencies.............                     653,000    (4,217,000)
  Other current assets..........................................                     605,000      (514,000)
  Other non-current assets......................................                       3,000       (12,000)
 Cash flows from increase (decrease) in operating liabilities:
  Accounts payable..............................................                    (796,000)      666,000
  Accrued salaries, wages and other liabilities.................                    (922,000)   (1,604,000)
  Unpaid self-insurance claims..................................                    (113,000)      135,000
  Amounts due to third-party contractual agencies...............                     596,000     1,293,000
                                                                                 -----------   -----------
   Total adjustments............................................                    (921,000)     (653,000)
                                                                                 -----------   -----------
    Net cash used in operating activities.......................                  (1,312,000)      (65,000)
                                                                                 -----------   -----------
Cash Flows from Investing Activities
 Expenditures for property and equipment........................                    (345,000)     (787,000)
 Preopening costs...............................................                     (22,000)     (296,000)
                                                                                 -----------   -----------
    Net cash used in investing activities.......................                    (367,000)   (1,083,000)
                                                                                 -----------   -----------
Cash Flows from Financing Activities
 Loan costs.....................................................                     (21,000)     (145,000)
 Proceeds from exercise of stock options and employee
     stock purchase plan........................................                      90,000        68,000
 Distributions to minority interests............................                    (540,000)   (1,116,000)
 Payments on debt...............................................                    (888,000)   (3,608,000)
 Payment of preferred stock dividends...........................                     (91,000)      (91,000)
 Purchase of treasury stock.....................................                         ---       (44,000)
 Restricted cash used for debt payments.........................                         ---     3,055,000
 Cash held in trust.............................................                     130,000        19,000
                                                                                 -----------   -----------
    Net cash used in financing activities.......................                  (1,320,000)   (1,862,000)
                                                                                 -----------   -----------
Net decrease in cash and cash equivalents.......................                  (2,999,000)   (3,010,000)
Cash and cash equivalents at beginning of period................                   9,044,000     6,207,000
                                                                                 -----------   -----------
Cash and cash equivalents at end of period......................                 $ 6,045,000   $ 3,197,000
                                                                                 ===========   ===========
 
Supplemental Disclosures of Cash Flow Information
Cash paid during the period for:
 Interest.......................................................                 $ 1,344,000   $ 1,747,000
 Income taxes...................................................                           0       616,000
 
</TABLE>
                See notes to consolidated financial statements.

                                       4
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)
                              SEPTEMBER 30, 1995


NOTE 1

          The accompanying unaudited consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-Q and Article 10 of
Regulation S-X.  Accordingly, they do not include all of the information and
notes required by generally accepted accounting principles for complete
financial statements.  In the opinion of management, all adjustments considered
necessary for a fair presentation of the interim information are, unless
otherwise discussed in this report, of a normal recurring nature and have been
included.  The Company's business is seasonal in nature and subject to general
economic conditions and other factors.  Accordingly, operating results for the
quarter ended September 30, 1995 are not necessarily indicative of the results
that may be expected for the year.  For further information, refer to the
consolidated financial statements and notes thereto included in the Company's
Annual Report on Form 10-K for the year ended June 30, 1995.

NOTE 2

          At September 30, 1995, the Company's credit facilities included
$34,168,750 in senior secured notes and $2,076,924 in subordinated secured notes
(the 1990 Credit Facility), and approximately $21,000,000 in letters of credit
(to support the Company's variable rate demand revenue bonds) and $2,000,000 in
a working capital facility (the 1993 Credit Facility).

          On May 1, 1995, the Company utilized a portion of the proceeds from a
sale/leaseback of two of its inpatient facilities and prepaid $7.5 million of
principal due on the senior secured notes as follows:  $3,531,250 in full
satisfaction of the amount due on September 30, 1995, $3,531,250 in full
satisfaction of the amount due on March 31, 1996, and $437,500 in partial
satisfaction of the $3,531,250 due on September 30, 1996.  The senior secured
notes bear interest at 11.6% and are due in semi-annual installments that began
on March 31, 1993 and, after the May 1, 1995 prepayment, resume semi-annual
installments on September 30, 1996 through March 31, 2000.  The subordinated
secured notes bear interest at 15.6% and are due in semi-annual installments
that began on March 31, 1994 and end on March 31, 2000.

          The variable rate demand revenue bonds were issued in 1984 and 1985,
have terms of 30 years and require annual principal payments of $800,000
(through year 2000) and $900,000 to $1,300,000 from years 2001 to maturity.
Amounts outstanding under the working capital facility, which totalled $1
million and $1.5 million at September 30, 1995 and June 30, 1995, respectively,
bear interest at a variable rate, which, at September 30, 1995, was 8.3%.
Effective September 15, 1995, the Company and the group of banks supporting the
1993 Credit Facility agreed to an extension of the facility to February 15,
1997.  In connection with this extension, certain financial covenants were
modified and the Company agreed to reduce the banks' exposure by $2.8 million on
or before December 31, 1995 and an additional $3.0 million on or before July 1,
1996.

                                       5
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES


A summary of the Company's debt obligations is as follows:

<TABLE>
<CAPTION>
 
                                      SEPTEMBER 30    JUNE 30
                                          1995         1995
                                      ------------  -----------
<S>                                   <C>           <C>
 
11.6% senior secured notes..........   $34,169,000  $34,169,000
Variable rate demand revenue bonds..    20,100,000   20,200,000
15.6% subordinated secured notes....     2,077,000    2,308,000
Capital lease obligation............       814,000      919,000
Working capital facility............     1,000,000    1,500,000
Other notes payable.................       351,000      303,000
                                       -----------  -----------
                                        58,511,000   59,399,000
Less amounts due within one year....     6,333,000    3,831,000
                                       -----------  -----------
                                       $52,178,000  $55,568,000
                                       ===========  ===========
 
</TABLE>

          The Company has pledged as collateral substantially all of its land,
buildings and improvements.

NOTE 3

          In April 1995, the Company sold and leased back the land, buildings
and fixed equipment of two of its inpatient facilities.  The leases have a
primary term of 15 years (with three successive renewal options of 5 years each)
and require aggregate annual minimum rentals of $1.54 million, payable monthly.
Beginning April 1, 1996, the lease payments are subject to any upward adjustment
(not to exceed 3% annually) in the consumer price index over the preceding
twelve months. Effective April 1995, the Company agreed to lease an 80-bed
facility near Salt Lake City, Utah for four years, with an option to renew for
an additional three years.  The lease requires annual base rental payments of
$456,000.  In addition, the lease provides for percentage rent payments to the
lessor equal to 2% of the net revenues of the facility, payable quarterly.  The
Company leases its Corporate headquarters for a term of five years ending in
April 1999 and various other clinics and outpatient operations over terms
ranging from one to five years.  Annual rent expense related to noncancellable
operating leases totals approximately 2.7 million.

NOTE 4

          The provision for income taxes included in the consolidated statements
of income differs from the amounts computed by applying the normal statutory
rates to income before income taxes because such provision includes a) amounts
reportable as income for federal income tax purposes which are not income for
financial reporting purposes, b) amounts deducted for financial reporting
purposes that are not allowable deductions for federal and state income tax
purposes and c) amounts for state income taxes applicable to profitable
subsidiaries which do not utilize the operating losses generated by unprofitable
subsidiaries to offset taxable income.  At September 30, 1995, the Company has
estimated operating loss carryforwards available to reduce future taxable income
of approximately

                                       6
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

$21 million, subject to significant annual limitations pursuant to Section 382
of the Internal Revenue Code of 1986, as amended.

NOTE 5

          Effective April 24, 1995, the Company distributed, on a pro-rata basis
in the form of a dividend, the common stock of its subsidiary, Ramsay Managed
Care, Inc. ("RMCI"), held by the Company, to the holders of record on April 21,
1995 of the Company's common and preferred stock (the "RMCI Distribution").
RMCI, which was formed in October 1993, manages the delivery of mental health
and substance abuse care and provides employee assistance and mental health and
substance abuse treatment programs for and on behalf of self insured employers,
health maintenance organizations ("HMOs"), insurance companies, government
agencies and other third-party payors. Subsequent to the RMCI Distribution, RMCI
ceased being a subsidiary of the Company.

          For the three months ended September 30, 1994, net revenues, operating
expenses and income before income taxes of RMCI were $3,463,000, $3,400,000 and
$63,000, respectively.  Inclusion of RMCI in the Company's consolidated results
of operations for the quarter ended September 30, 1994 had no effect on the
earnings per share reported in that quarter.

          At September 30, 1995, total net cash advances made by the Company to
or on behalf of RMCI, including for purposes of partially funding acquisitions
and for working capital and other corporate purposes, totalled approximately
$7.6 million.  Of this amount, $6 million is represented by an unsecured,
interest-bearing (8%), subordinated promissory note due from RMCI and issued on
October 25, 1994.  Interest on the subordinated promissory note, which is
payable quarterly, commenced June 30, 1995 and principal is payable over a four-
year period in equal quarterly installments commencing September 30, 1996.

          In addition to the subordinated promissory note and pursuant to a
Distribution Agreement between RHCI and RMCI which governed the RMCI
Distribution, RMCI agreed to pay amounts owed to RHCI as of April 24, 1995 (the
"Distribution Date") totalling approximately $1,100,000. Pursuant to the
Distribution Agreement, $600,000 of this amount was payable by RMCI on or before
October 21, 1995 or on such other date and on such other terms and conditions as
mutually agreed to by RHCI and RMCI.  RMCI paid $275,000 to RHCI on June 30,
1995 in partial satisfaction of the amount due on October 21, 1995 and the
parties are currently discussing deferred payment terms on the remaining
$325,000. The balance of the amount outstanding on the Distribution Date,
approximately $500,000, is payable on or before December 31, 1996, together with
interest at 7% per annum accruing from October 21, 1995, or on such other date
and on such other terms and conditions as shall be mutually agreed to between
RHCI and RMCI.

          Subsequent to the RMCI Distribution, RHCI paid additional amounts
incurred by RMCI prior to the Distribution Date and provided certain
administrative services to RMCI pursuant to certain agreements entered into in
connection with the RMCI Distribution. RHCI will be paid for these amounts,
which at September 30, 1995 totalled approximately $725,000, on terms currently
being discussed between the parties.

                                       7
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

          The Company pursues business expansion opportunities which are
consistent with its overall strategic plan and disposes of operations no longer
considered viable or consistent with this plan. The following significant
events, which occurred subsequent to September 30, 1994, impact the comparison
of revenues and operating expenses of the Company between the periods presented.

  *  The RMCI Distribution.

  *  Virtual elimination (due to statutory changes effective July 1, 1995)
     of disproportionate share payments to the Company.  Disproportionate share
     was a funding mechanism designed to adequately reimburse facilities serving
     a disproportionately high volume of Medicaid patients, relative to other
     providers.  The majority of disproportionate share payments were received
     at the Company's Three Rivers facility,  which was operated as a limited
     partnership in which the Company had a 55% interest and limited partners
     maintained a 45% interest.  Due to the virtual elimination of
     disproportionate share payments effective July 1, 1995, as well as
     significantly more restrictive admission criteria imposed by the State of
     Louisiana on behavioral health providers treating adolescents in the State,
     the Three Rivers facility was closed in June 1995.

  *  Commencement of operations in April 1995 at an 80-bed leased facility
     near Salt Lake City, Utah.

  *  The closure of several day treatment centers and outpatient clinics
     during fiscal 1995 due to negative operating margins.

  *  Expansion of the Company's contract services division during fiscal
     1995.

                                       8
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

RESULTS OF OPERATIONS

     The following table sets forth, for the period indicated, certain items of
the Company's Consolidated Statements of Operations as a percentage of the
Company's net revenues.  The prior year percentages have been adjusted to
exclude the operations of RMCI.
<TABLE>
<CAPTION>
 
                                                  PERCENTAGE OF NET REVENUES
                                                         QUARTER ENDED
                                                          SEPTEMBER 30
                                                  --------------------------
                                                    1995            1994  
                                                  -------         -------
<S>                                               <C>             <C>   
Net revenues..........................             100.0%          100.0%
Operating expenses:                                                      
 Salaries, wages and benefits.........              55.7            50.4 
 Other operating expenses.............              32.8            28.9 
 Provision for doubtful accounts......               3.3             3.9 
 Depreciation and amortization........               4.6             5.0 
 Interest expense.....................               5.9             6.5 
                                                  ------           ----- 
Total operating expenses..............             102.3            94.7 
                                                  ------           ----- 
Income before minority interests and                                     
 income taxes.........................              (2.3)            5.3 
                                                                         
Minority interests....................              (0.1)            2.6 
                                                  ------            ---- 
Income before income taxes............              (2.2)            2.7 
                                                  ======            ====  
 
</TABLE>

          Net revenues in the quarter ended September 30, 1995 were $29.1
million, compared to $35.8 million in the comparable quarter of the prior fiscal
year.  The material changes in net revenues between these periods consisted of
(a) a $1.3 million decrease in same facility net inpatient revenues between
periods, (b) a $0.2 million decrease in same facility net outpatient revenues
between periods, (c) a decrease in net patient revenues of $4.4 million (of
which $2.2 million was disproportionate share revenues) due to the closure of
the Three Rivers facility, (d) an increase in net patient revenues of $1.2
million related to the opening of an additional facility near Salt Lake City,
Utah ("Benchmark South"), (e) a $1.2 million increase in net patient revenues
related to the Company's subacute operations, (f) a $0.3 million increase in net
revenues related to the Company's contract services division, and (g) net
revenues in the quarter ended September 30, 1994 related to RMCI of $3.5
million.

          Same facility net inpatient revenues decreased 6% between periods
(from $22.3 million in the September 1994 quarter to $21.0 million in the
current year quarter) which was consistent with the 5% decrease in same facility
patient days between periods.  The increase in net revenues related to subacute
operations is due to the opening of an additional unit after the September 1994
quarter and a significant increase in census between periods at one of the
Company's other three subacute units.

          Salaries, wages and benefits in the quarter ended September 30, 1995
were $16.2 million, compared to $17.7 million in the comparable quarter of the
prior fiscal year.  Same facility salaries, wages and benefits increased $0.5
(from $13.1 million to $13.6 million) between periods, or 4%.

                                       9
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

Other changes to salaries, wages and benefits between periods included (a) a
decrease of $1.6 million related to the closure of the Three Rivers facility,
(b) an increase of $0.7 million related to the opening of Benchmark South, (c)
an increase of $0.2 million related to subacute operations, (d) an increase of
$0.2 million related to the contract services division and (e) salaries, wages
and benefits in the quarter ended September 30, 1994 related to RMCI of $1.4
million.

          Other operating expenses in the quarter ended September 30, 1995 were
$9.6 million, compared to $11.0 million in the comparable quarter of the prior
fiscal year.  Same facility other operating expenses increased $0.3 million
between periods ($7.4 million in the current quarter compared to $7.1 million in
the prior fiscal year quarter) whereas other operating expenses of RMCI in the
quarter ended September 30, 1994 were $1.6 million.  The decrease in other
operating expenses between periods due to the closure of the Three Rivers
facility was offset by the increase in other operating expenses due to the
opening of Benchmark South.

          The provision for doubtful accounts in the quarter ended September 30,
1995 totalled $1.0 million, compared to $1.3 million in the prior year
comparable quarter.  The overall provision for doubtful accounts associated with
the same facilities decreased $0.3 million between periods due to the continued
shift in the Company's overall payor mix away from charged-based payors, which
typically include a higher patient portion due and, consequently, higher bad
debts.

          Depreciation and amortization in the quarter ended September 30, 1995
totalled $1.3 million, compared to $1.8 million in the prior year comparable
quarter.  This decrease is due to (a) the closure of the Three Rivers facility
($0.1 million), (b) depreciation and amortization in the quarter ended September
30, 1994 related to RMCI of $0.2 million and (c) an asset write-down recorded by
the Company in the fourth quarter of its prior fiscal year, which reduced
depreciation expense on the underlying assets between periods by $0.1 million.

          Interest expense decreased from $2.2 million in the quarter ended
September 30, 1994 to $1.7 million in the current year comparable quarter.  Debt
levels were reduced between periods through regularly scheduled principal
payments and a prepayment of principal on the senior secured notes, a $0.5
million reduction in principal on the subordinated secured notes and a $0.8
million reduction in principal on the variable rate demand revenue bonds. In
addition, interest costs included in the September 30, 1994 quarter related to
RMCI were not incurred in the current year quarter.

          Minority interests reflects the limited partners' share of income
before income taxes of the Three Rivers facility.  The decrease in minority
interests between periods is due to the closure of this facility in June 1995.

FINANCIAL CONDITION

          The Company records amounts due to or from third-party contractual
agencies (Medicare, Medicaid and Blue Cross) based on its best estimate, using
the principles of cost reimbursement, of amounts to be ultimately received or
paid under current and prior years' cost reports filed (or to be filed) with the
appropriate intermediaries.  Ultimate settlements and other lump-sum adjustments
due from and paid to these intermediaries occur at various times during the
fiscal year.  At September

                                       10
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

30, 1995, amounts due from Medicare, Medicaid and Blue Cross totalled $2.7
million, $1.2 million and $1.4 million, respectively.  Also at September 30,
1995, amounts due to Medicare, Medicaid and Blue Cross totalled $4.4 million,
$1.0 million and $0.2 million, respectively.

          During the three months ended September 30, 1995, amounts owed to
minority interests decreased by a total of $0.6 million due primarily to
distributions made to the minority partners in the Three Rivers Hospital Limited
Partnership.  In addition, the current portion of long-term debt increased
approximately $2.5 million since June 30, 1995 because, on September 30, 1995,
$3.1 million in principal on the senior secured notes came due within one year.
This increase was offset by a $0.2 million principal payment on the subordinated
secured notes and a $0.5 million reduction in the amount drawn under the working
capital facility during the September 1995 quarter.

          The Company has net deferred tax assets of approximately $8.9 million
at September 30, 1995.  Management has considered the effects of implementing
tax planning strategies, consisting of the sales of certain appreciated
property, as the primary basis for not recognizing a valuation allowance related
to its deferred tax assets at September 30, 1995.  The ultimate realization of
deferred tax assets may be affected by changes in the underlying values of the
properties considered in the Company's tax planning strategies, which values are
dependent upon the operating results and cash flows of the individual
properties.  The Company evaluates the realizability of its deferred tax assets
on a quarterly basis by reviewing its tax planning strategies and assessing the
need for a valuation allowance.

LIQUIDITY AND CAPITAL RESOURCES

          The Company's credit facilities include $34.2 million in senior
secured notes, approximately $21 million in letters of credit, $2.1 million in
subordinated secured notes and $2.0 million in a working capital facility.  The
senior secured notes bear interest at 11.6% and are payable as follows: (a) $3.1
million due on September 30, 1996, (b) semi-annual principal payments of $3.5
million from March 31, 1997 through September 30, 1998 and (c) semi-annual
principal payments of $5.65 million from March 31, 1999 through March 31, 2000.
The subordinated secured notes bear interest at 15.6% and require semi-annual
principal payments of $0.2 million through March 31, 2000. Required annual
principal payments on the variable rate demand revenue bonds total $0.8 million
through year 2000 and $0.9 million to $1.3 million in years 2001 through 2015.
Amounts outstanding under the working capital facility, which totalled $1.0
million at September 30, 1995, bear interest at a variable rate.  The amount
drawn is structured as a revolving credit loan, bearing interest at 8.3% and
renewable in 30, 60 and 90-day increments, at the option of the Company.  Under
the provisions of the Company's Credit Agreement, which governs the terms of the
letters of credit and the working capital facility, amounts outstanding under
the working capital facility must be reduced to zero for 30 consecutive days in
each fiscal year.

          In September 1995, the Company and the banks supporting the Credit
Agreement agreed to terms which extend the expiration date of the Credit
Agreement from May 15, 1996 to February 15, 1997.  In connection with this
extension, the Company agreed to reduce the banks' exposure (through regular
principal payments on the variable rate demand revenue bonds outstanding, early
redemption of certain of these bonds and/or elimination of the working capital
facility) by $2.8 million on or

                                       11
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

before December 31, 1995 and an additional $3 million on or before July 1, 1996.
Management expects to satisfy the December 31, 1995 reduction in the banks'
exposure by paying back the amount currently drawn and eliminating the working
capital facility.

          At the current time, the Company does not have any commitments to make
any material capital expenditures.  The Company's current primary cash
requirements relate to its normal operating expenses, the requirement to reduce
its banks' credit exposure as discussed above, routine capital improvements at
its facilities and selective expansion of outpatient programs and services. In
addition, at the current time, the Company's specific development projects
include expansion of its contract services division and its network of
affiliations with medical/surgical hospitals and other healthcare providers.
Construction costs related to the Company's subacute business were completed
during fiscal 1995 and this business began generating positive cash flow from
operations in the fourth quarter of fiscal 1995.  Also, during 1995, the Company
closed outpatient day treatment centers and other outpatient clinics which were
experiencing negative cash flow.

          On the basis of its historical experience and projected cash needs,
the Company believes that its existing cash resources, internally generated
funds from operations and funds derived from any future asset sales will be
sufficient to fund its current cash requirements and future identifiable needs.
At the present time, the Company does not have any agreement to sell any of its
assets.

OTHER MATTERS

          In October 1995, a corporate affiliate of Paul J. Ramsay, the Chairman
of the Board of the Company, acquired through private placement an aggregate of
275,863 shares of common stock of the Company at a price of $3.625 per share.
Of the total shares acquired, 121,363 were issued for cash and 154,500 were
issued for management fees due during the remainder of the Company's current
fiscal year under the Company's management agreement with another corporate
affiliate of Mr. Ramsay.  With the issuance of the additional shares, the voting
power of the interests in the Company controlled by Mr. Ramsay increased from
approximately 30.9% to approximately 32.9%.

                                       12
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

                          PART II - OTHER INFORMATION


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

     (a) Exhibits

         The exhibits required to be filed as part of this Quarterly
         Report on Form 10-Q are as follows:

     Exhibit 10.99

         Second Amendment to Credit Agreement dated as of September 15, 1995
         among the Company and certain of its subsidiaries named therein,
         Societe Generale, New York Branch, First Union National Bank of North
         Carolina and Hibernia National Bank, as lenders, and Societe Generale,
         as issuing bank and agent.

     Exhibit 10.100

         Fourth Supplemental Trust Indenture dated as of September 15, 1995
         between the Company, Bountiful Psychiatric Hospital, Inc., Cumberland
         Mental Health, Inc., East Carolina Psychiatric Services Corporation,
         Havenwyck Hospital, Inc., Mesa Psychiatric Hospital, Inc. and
         Psychiatric Institute of West Virginia, Inc. and NationsBank of
         Georgia, National Association and Elizabeth Talley, as Trustees.

     Exhibit 10.101

         Amended and Restated Stock Purchase Agreement dated October 12, 1995 by
         and among Paul Ramsay Holdings Pty. Limited, Ramsay Health Care, Inc.
         and, solely for the purposes of Section I, III and VI of the agreement,
         Ramsay Health Care Pty. Limited.

     Exhibit 10.102

         Amendment to Rights Agreement, dated October 3, 1995 between Ramsay
         Health Care, Inc. and First Union National Bank of North Carolina, as
         Rights Agent.

     Exhibit 11

         Computation of Net Income per Share

     Exhibit 27

         Financial Data Schedule

 
 

                                       13
<PAGE>
 
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

     (b)  Current Reports on Form 8-K

          During the quarter ended September 30, 1995, the Company filed the
following Current Reports on Form 8-K with the Commission:

     *  Form 8-K dated August 1, 1995 relating to the Company's adoption
        of a Stockholder Rights Plan.

     *  Form 8-K dated June 30, 1994 relating to the acquisition of a
        business on June 30, 1994. This filing was made during the quarter ended
        September 30, 1995, pursuant to applicable rules of the Commission.

     *  Form 8-K dated October 29, 1993 relating to the acquisition of a
        business on October 29, 1993. This filing was made during the quarter
        ended September 30, 1995, pursuant to applicable rules of the
        Commission.

                                       14
<PAGE>
 
                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereupon duly authorized.


                              RAMSAY HEALTH CARE, INC.
                              Registrant


                              /s/ Daniel A. Sims
                              ------------------------------------
                              Daniel A. Sims
                              Corporate Controller
 



Date:  November 20, 1995

                                       15

<PAGE>
 
                                                                   EXHIBIT 10.99

                               SECOND AMENDMENT
                                      TO
                               CREDIT AGREEMENT


     This SECOND AMENDMENT dated as of September 15, 1995 (this "Amendment") to 
the Credit Agreement dated as of May 15, 1993 (the "Credit Agreement") among 
RAMSAY HEALTH CARE, INC. (the "Company"), a Delaware corporation, GREENBRIER 
HOSPITAL, INC. ("Greenbrier"), a Louisiana corporation, HOUMA PSYCHIATRIC 
HOSPITAL, INC. ("Houma"), a Louisiana corporation, HSA OF OKLAHOMA, INC. 
("HSA"), an Oklahoma corporation, CAROLINA TREATMENT CENTER, INC. ("Carolina"), 
a South Carolina corporation, GULF COAST TREATMENT CENTER, INC. ("Gulf Coast"), 
a Florida corporation, and ATLANTIC TREATMENT CENTER, INC. ("Atlantic"), a 
Florida corporation, as Borrowers (collectively, the "Borrowers"), GREAT PLAINS 
HOSPITAL, INC., a Missouri corporation, and THE HAVEN HOSPITAL, INC., a Delaware
corporation, as Guarantors (collectively, the "Guarantors"), SOCIETE GENERALE, a
French banking corporation acting by and through its New York Branch, FIRST 
UNION NATIONAL BANK OF NORTH CAROLINA, a national banking association, and 
HIBERNIA NATIONAL BANK, a national banking association, as Lenders 
(collectively, the "Lenders"), and SOCIETE GENERALE, as the issuer of the 
Letters of Credit described in the Credit Agreement (in such capacity, the 
"Issuing Bank") and as agent for the Lenders as provided in the Credit Agreement
(in such capacity, the "Agent"),


                             W I T N E S S E T H :

     A.  Pursuant to the Credit Agreement, at the request of the Borrowers, the 
Issuing Bank issued the Letters of Credit to support certain Bonds theretofore 
issued to finance certain hospital assets for the benefit of the Borrowers. 
Subsequent to the original issuance of the Letters of Credit, (i) the Letter of 
Credit issued for the account of Atlantic was terminated in connection with the 
sale of Atlantic's hospital assets and (ii) the other Letters of Credit have 
been reduced in connection with mandatory sinking fund payments of principal of 
the Bonds supported by such Letters of Credit. As of the date of this Amendment,
the outstanding Letters of Credit and the respective amounts thereof are as 
follows:
<PAGE>
 
<TABLE> 
<CAPTION> 

                                LETTER OF                                                               INTEREST
  ACCOUNT                        CREDIT               PRINCIPAL                 INTEREST                COVERAGE
   PARTY                         AMOUNT               COMPONENT                 COMPONENT               CALCULATION
  -------                   ------------------     -----------------       --------------------    ---------------------
<S>                         <C>                    <C>                     <C>                     <C> 
Greenbrier                   $ 5,553,958.34         $ 5,300,000.00             $253,958.34             115 days @ 15%
                                                                                                       360-day year

Houma                          3,665,410.95           3,500,000.00              165,410.95             115 days @ 15%
                                                                                                       365-day year

HSA                            3,236,740.00           3,100,000.00              136,740.00             115 days @ 14%
                                                                                                       365-day year

Carolina                       4,610,833.34           4,400,000.00              210,833.34             115 days @ 15%
                                                                                                       360-day year

Gulf Coast                     3,974,166.66           3,800,000.00              174,166.66             110 days @ 15%
                            ------------------     -----------------       --------------------        360-day year 
  
  TOTAL                      $21,041,109.29         $20,100,000.00             $941,109.29
</TABLE> 

        B. The Credit Agreement also provided for Revolving Credit Loans by the
Lenders to the Company up to a maximum aggregate outstanding principal balance
of $4,000,000 to provide working capital for conducting the operations of the
Company and certain of its consolidated subsidiaries. Pursuant to Section
2.04(g) of the Credit Agreement, by letter dated as of April 12, 1995, the
Company irrevocably elected to permanently reduce the Revolving Credit Maximum
Commitment Amount from $4,000,000 to $2,000,000. Pursuant to the Credit
Agreement, the Lenders' Revolving Credit Commitment expires on May 15, 1996.

        
        C.  As of the date of this Amendment, the maximum credit available to be
outstanding for the benefit of the Borrowers pursuant to the Credit Agreement 
(the Maximum Credit Availability as defined herein) is $23,041,109.29 (up to 
$21,041,109.29 under the Letters of Credit or, in the event of conversion to one
or more Term Loans, up to $20,100,000.00 under the Term Loan Commitments, plus 
up to $2,000,000.00 under the Revolving Credit Commitment).

        D. Pursuant to a Consent and Amendment dated as of April 12, 1995 among
the Borrowers, the Guarantors, the Lenders, the Issuing Bank and the Agent (the
"First Amendment"), (i) the Agent, on behalf of the Lenders, consented to the
consummation of certain sale-leaseback transactions between two wholly-owned
subsidiaries of the Company and Capstone Capital Corporation and (ii) Section
2.04(f) of the Credit Agreement was amended by adding the following provision to
the end of such Section:
 
                                       2

<PAGE>

        "; provided that no proceeds of the Revolving Credit Loans shall be used
by the Company to fund working capital or other capital needs of Mesa
Psychiatric Hospital, Inc."
 
        E. The Borrowers have requested the Lenders, the Agent and the Issuing
Bank (collectively in such capacities, the "Banks") (1) to extend the stated
expiration date of the Letters of Credit from May 15, 1996 to February 15, 1997,
(2) to extend the Revolving Credit Termination Date from May 15, 1996 to
February 15, 1997, and (3) to agree to certain amendments to the Credit
Agreement. Upon the terms and conditions set forth in this Amendment, the Banks
are willing (a) to extend the stated expiration date of the Letters of Credit,
(b) to extend the Revolving Credit Termination Date, and (c) to agree to certain
amendments to the Credit Agreement, all as hereinafter provided.

        NOW, THEREFORE, in consideration of the foregoing and the understandings
herein set forth and intending to be legally bound, the Borrowers, the 
Guarantors, the Lenders, the Issuing Bank and the Agent hereby agree as follows:

        1.  Definitions.  As used in this Amendment and in the Credit Agreement,
the term "Agreement" shall mean the Credit Agreement as amended by the First 
Amendment and this Amendment. All terms used herein and not otherwise defined 
shall have the meanings ascribed to such terms in the Credit Agreement, as 
certain of such meanings are amended as hereinafter provided.  In addition, as 
used in this Amendment and the Credit Agreement, the following terms shall have 
the meanings specified below:

        "EBITDA" as to any Person means, with respect to a specified 12-month 
period, (i) Pre-Tax Net Income for such 12-month period, plus (ii) all Interest 
Expense for such 12-month period, plus (iii) all depreciation expense, 
amortization of financing charges and other non-cash expense for such 12-month 
period.

        "Maximum Credit Availability" means the maximum credit available to be
outstanding for the benefit of the Borrowers pursuant to the Credit Agreement, 
including (i) the total of the Letter of Credit Amounts, plus the aggregate 
amount of any unreimbursed draws under the Letters of Credit, or the principal 
amount of any outstanding Term Loans in the event of conversion to one or more 
Term Loans, plus (ii) the Revolving Credit Maximum Commitment Amount.

        2.  Extension of Letters of Credit.  The Borrowers hereby request the 
Banks to extend the stated expiration date of the Letters of Credit to February 
15, 1997. Subject to the payment of the extension fee set forth in section 4 of 
this

                                       3

<PAGE>
 
Amendment and to the other conditions precedent hereinafter set forth, the 
Issuing Bank will extend the stated expiration date of the Letters of Credit to 
February 15, 1997, such extension to be effected through the issuance by the 
Issuing Bank to the Greenbrier Trustee, the Houma Trustee, the HSA Trustee, the 
Carolina Trustee and the Gulf Coast Trustee, respectively, of an Amendment No. 1
to each of the outstanding Letters of Credit effective as of September 15, 1995.

        3.  Extension of Revolving Credit Termination Date.  The Company hereby 
requests the Lenders to extend the Revolving Credit Termination Date to February
15, 1997.  Subject to the payment of the extension fee set forth in section 4 of
this Amendment and to the other conditions precedent hereinafter set forth, the 
Lenders agree that the Credit Agreement is hereby amended to extend the 
Revolving Credit Termination Date (and thereby extend the maturity date of the 
Revolving Credit Note) to February 15, 1997.

        4.  Extension Fee.  On the date of execution and delivery of this 
Amendment, the Company shall pay to the Agent in immediately available funds a 
nonrefundable extension fee in the amount of $50,000.  Such extension fee shall 
be shared by the Lenders pro rata on the basis of their respective Percentages.

        5.  Amendments to Credit Agreement.

                5.1  The definitions of the following terms set forth in Section
1.01 of the Credit Agreement are hereby amended and restated in full as follows:

                        "Base Rate Increment" means one percent (1%) per annum.
        
                        "Commitment Fee Rate" means, at any time, (i) two and 
        three-quarters percent (2 3/4%) per annum if the Debt Service and Lease
        Payment Coverage Ratio of the Consolidated Companies for the most recent
        12-month period for which financial statements of the Consolidated
        Companies have been provided to the Agent pursuant to Section 7.12 is
        greater than 1.25 to 1, (ii) three percent (3%) per annum if such Debt
        Service and Lease Payment Coverage Ratio is equal to or less than 1.25
        to 1 and equal to or greater than 1.00 to 1, and (iii) four percent (4%)
        per annum if such Debt Service and Lease Payment Coverage Ratio is less
        than 1.00 to 1; provided that, if and so long as such Debt Service and
        Lease Payment Coverage Ratio of the Consolidated Companies is greater
        than 1.25 to 1 and no Event of Default has occurred and is continuing,
        the Commitment Fee Rate shall be reduced by one-

                                       4

<PAGE>
 
        quarter percent (1/4%) for each permanent reduction from and after 
        September 15, 1995 of $3,000,000 in the Maximum Credit Availability.

                        "Eurodollar Rate Increment" means two and three-quarters
        percent (2 3/4%) per annum.

                        "Long-Term Debt" means all Debt which, on the date of 
        incurrence, has a final maturity or term greater than one year or which
        is renewable at the option of the debtor for a term greater than one
        year from the date of original incurrence.

                5.2.  Section 2.03(a) of the Credit Agreement is hereby amended 
and restated in full as follows:

                        (a)  Conversion to Term Loans.  With respect to each 
        Letter of Credit, the Lenders agree that, subject to and upon
        satisfaction of the terms and conditions contained in this Section and
        so long as the Term Loan Commitments have not theretofore been
        terminated, the aggregate amount of the related Subsidiary Borrower's
        unpaid reimbursement obligations under Section 2.02 on the date
        specified by the Company pursuant to Section 2.03(b)(1) in respect of
        amounts drawn against the Principal Component of the Letter of Credit
        Amount of such Letter of Credit shall be converted to a Term Loan on
        such date. The original principal amount of each Term Loan shall not
        exceed the lesser of (1) the related Term Loan Commitment Amount, (2)
        the aggregate Outstanding balance of the related Bonds immediately prior
        to the payment of the final drawing under the related Letter of Credit,
        less (i) the aggregate amount of all moneys held by the respective
        Trustee in the funds established under the related Indenture available
        to reimburse the Lenders, (ii) the principal of the related Bonds (other
        than Pledged Bonds) which will remain outstanding after the final
        drawing under the related Letter of Credit, and (iii) the principal
        amount of the related Bonds for which refunding bonds have been or will
        be issued, and (3) 75% of the then current appraised value of the real
        property of the Subsidiary Borrower to which such Term Loan is being
        made which is subject to a first lien priority Mortgage that will secure
        such Term Loan, plus 75% of the appraisal value of any additional real
        property collateral provided by the Obligors and satisfactory to the
        Lenders in which the Lenders already have or are given a first lien
        priority mortgage so as to result in a Term Loan to collateral value
        ratio of not greater than 75% (provided that in
                
                                   5        
<PAGE>
        calculating such ratio there shall be deducted from the appraised value
        of any such additional collateral the amount thereof allocated to
        provide collateral coverage at the same ratio for any and all other
        obligations owing to the Lenders secured by such collateral). With
        respect to each Subsidiary Borrower, the related Term Loan Commitment
        and the Lenders' obligation to permit conversion to a Term Loan under
        this Section shall terminate as of the close of business of the Agent at
        its Lending Office on the first to occur of (A) the date the related
        Letter of Credit terminates, (B) the first date on which there are no
        longer any related Bonds Outstanding other than Bonds secured by a
        Substitute Letter of Credit, and (C) the date the Agent terminates the
        Term Loan Commitments pursuant to Section 8.02.

        5.3.  Section 2.03(b)(3) of the Credit Agreement is hereby amended and 
restated in full as follows:

                (3)  Receipt by the Agent of (i) an endorsement to the mortgage 
        title insurance policy delivered pursuant to Section 4.04 insuring, in
        favor of the Agent for the benefit of the Lenders, that the Mortgage
        delivered by such Subsidiary Borrower secures the Subsidiary Borrower
        Note evidencing such Term Loan and that there have been no intervening
        liens since the original issuance of such mortgage title insurance
        policy, (ii) evidence of comparable mortgage title insurance in favor of
        the Agent for the benefit of the Lenders with respect to the mortgage on
        any additional real property collateral intended to satisfy the loan to
        collateral value ratio requirement of Section 2.03(a), and (iii) an
        appraisal (or appraisals) of the real property covered by such Mortgage
        (or additional mortgage) in compliance with federal and state laws
        applicable to the Lenders, prepared by an appraiser satisfactory to
        Lenders, dated as of a date no more than 60 days prior to the date of
        conversion to such Term Loan, valuing such real property (and any such
        additional real property collateral) in an amount sufficient to provide
        a Term Loan to collateral value ratio of at least 75%;

        5.4.  Section 2.04(c) of the Credit Agreement is hereby amended and 
restated in full as follows:

                        (c) Revolving Credit Interest Rate. The unpaid principal
        balance of each Revolving Credit Loan shall bear interest from the date
        such Revolving Credit Loan is made until the principal balance thereof
        is

                        
                                       6

<PAGE>
 
                paid in full at a fluctuating rate per annum equal to (1) in the
                case of a Base Rate Loan, the Base Rate plus one percent (1%)
                per annum, computed for the actual number of days elapsed
                (including the first day but excluding the last day) based on a
                360-day year, and (2) in the case of a Eurodollar Loan, the
                Eurodollar Rate plus two and one-half (2 1/2%) per annum,
                computed for the actual number of days elapsed (including the
                first day but excluding the last day) based on a 360-day year.
                The Company shall pay interest on Base Rate Loans to the Agent
                for the accounts of the Lenders monthly in arrears on the first
                Business Day of each calendar month or, if sooner, on the
                Revolving Credit Termination Date. The Company shall pay
                interest on Eurodollar Loans to the Agent for the accounts of
                the Lenders in arrears in the last day of the applicable
                Interest Period, or, if sooner, on the Revolving Credit
                Termination Date. Upon the occurrence and during the continuance
                of an Event of Default, the rate of interest on the outstanding
                principal balance of the Revolving Credit Loans shall be
                increased to a rate per annum equal to two and one-half percent
                (2 1/2%) per annum above the rate otherwise payable wth respect
                to such Revolving Credit Loans at such time. Each determination
                by the Agent of a Revolving Credit Loan interest rate under this
                Agreement and the Revolving Credit Note shall be conclusive and
                binding for all purposes, absent manifest error.

                5.5.  Section 2.04(e)(4) of the Credit Agreement is hereby 
amended and restated in full as follows:

                        (a) Annual Clean-Up Period. For a clean-up period of 30
                consecutive days in each Fiscal Year the aggregate amount of the
                Revolving Credit Loans outstanding shall be reduced to zero, and
                the Company shall prepay to the Agent for the accounts of the
                Lenders the aggregate outstanding balance of all Revolving
                Credit Loans, together with all accrued but unpaid interest on
                such balance through the Business Day immediately preceding the
                date of commencement of such clean-up period, and all other
                fees, costs and amounts (if any) payable under this Agreement or
                the Revolving Credit Note in connection with such prepayment on
                such Business Day.

                5.6.  Section 2.04(f) of the Credit Agreement is hereby amended 
and restated in full as follows:

                        (f) Use of Revolving Credit Proceeds.  The proceeds of 
                the Revolving Credit Loans shall be used by

                                       7

<PAGE>
 
                the Company solely for working capital (including, without
                limitation, short-term bridge financing of fixed assets) of the
                Obligors, the Life Company Subsidiaries and the Other Revolving
                Credit Subsidiaries; provided that no proceeds of the Revolving
                Credit Loans shall be used by the Company to fund working
                capital or other capital needs of Mesa Psychiatric Hospital,
                Inc. In no case shall such proceeds be used, directly or
                indirectly, to pay reimbursement obligations with respect to the
                Letters of Credit or to repay the Life Company Senior Notes, the
                Life Company Subordinated Notes or any other Debt of the Company
                or any of its Subsidiaries.

                5.7.  Section 7.12(a) of the Credit Agreement is hereby amended 
by adding the following clauses (7) and (8) to the end of such Section:

                        (7) a report as of the end of such quarter of the 
                Obligors' status with respect to (i) permitted additional debt
                incurred pursuant to Section 7.13, permitted loans, advances,
                capital expenditures and other investments made pursuant to
                Section 7.20 (provided that such requirement to report the
                Obligors' status with respect to Section 7.20 shall start with
                the fiscal quarter ending December 31, 1995), and permitted
                obligations under Operating Leases under Section 7.22; and

                        (8) a report on the current status of any and all 
                significant ongoing efforts or proposals to sell any of the
                hospital facilities operated by any of the Subsidiary Borrowers
                (including specific information with respect to the Harbor Oaks
                Hospital and the Coastal Carolina Hospital) or by any of the
                Guarantors, the Life Company Subsidiaries or the Other
                Consolidated Subsidiaries; provided that any and all significant
                developments occurring with respect to any such proposed sales
                shall be reported to the Bank in writing as soon as possible and
                not later than 15 days after the occurrence of such
                developments.


                5.8.  Section 7.12 of the Credit Agreement is hereby further 
amended by adding the following subsection (o) to end of Section 7.12 as an 
additional requirement for information to be furnished pursuant to Section 7.12:

                        (o) Monthly Reports.  As soon as available and in any 
                event within 30 days after the close of each calendar month:

                                       8

<PAGE>

                                (1) unaudited consolidated and consolidating 
                        financial statements for the Consolidated Companies,
                        including consolidated balance sheets and related
                        consolidated and consolidating statements of income as
                        of the end of such month and for such month and the
                        current Fiscal Year to the end of such month, which
                        shall be internally prepared and presented on a
                        consistent basis and, in the case of consolidated
                        financial statements, in accordance with GAAP (without
                        footnotes and subject to normal year-end adjustments);
                        and

                                (2) a report on the utilization of the
                        Consolidated Companies' Facilities operated by the
                        Consolidated Companies for such month and the current
                        Fiscal Year to the end of such month, including number
                        of beds in service, admissions, patient days, average
                        length of stay and occupancy, all in such reasonable
                        detail as the Agent may request.

                5.9. Section 7.16 of the Credit Agreement is hereby amended and 
restated in full as follows:

                (a) Consolidated Maximum Annual Debt Service and Lease Payment
        Coverage Ratio. The Obligors will maintain, and the Company will cause
        the other Consolidated Companies to maintain, as to the Consolidated
        Companies on a consolidated basis, as of the end of each fiscal quarter
        of the Consolidated Companies for the 12-month period then ended, a
        Maximum Annual Debt Service and Lease Payment Coverage Ratio of at least
        the following amounts from and after the date indicated:

<TABLE> 
<CAPTION> 
   From and                              Maximum Annual Debt Service
after June 30                         and Lease Payment Coverage Ratio
- -------------                         --------------------------------
<S>                                   <C> 
    1995                                         1.00 to 1
    1996                                         1.10 to 1
</TABLE> 

                (b) Consolidated Fixed Charge Coverage Ratio. The Obligors will
        maintain, and the Company will cause the other Consolidated Companies to
        maintain, as to the Consolidated Companies on a consolidated basis, as
        of the end of each fiscal quarter of the Consolidated Companies for the
        12-month period then ended, a Fixed Charge Coverage Ratio of at least
        the following amounts from and after the date indicated:


                                       9

<PAGE>


<TABLE> 
<CAPTION> 
   From and                                                         
after June 30                         Fixed Charge Coverage Ratio     
- -------------                         ---------------------------
<S>                                   <C> 
    1995                                           1.50    
    1996                                           1.75
</TABLE> 

                (c) Consolidated Current Ratio.  The Obligors will maintain, and
        the Company will cause the other Consolidated Companies to maintain, as
        to the Consolidated Companies on a consolidated basis at all times a 
        Current Ratio of at least 1.50 to 1.

                (d) Consolidated Leverage Ratio. The Obligors will maintain, and
        the Company will cause the other Consolidated Companies to maintain, as
        to the Consolidated Companies on a consolidated basis at all times a
        Leverage Ratio of not more than 1.50 to 1.

                (e) Consolidated Tangible Net Worth. The Obligors will maintain,
        and the Company will cause the other Consolidated Companies to maintain,
        at all times a Consolidated Tangible Net Worth of at least $48,000,000.

                (f) Additional Maximum Annual Debt Service and Lease Payment
        Coverage Ratio. The Subsidiary Borrowers and Guarantors will maintain,
        as a consolidated group, as of the end of each fiscal quarter of such
        group for the 12-month period then ended, a Maximum Annual Debt Service
        and Lease Payment Coverage Ratio of at least 3.00 to 1.

                (g) Short-Term Debt. The Obligors will not permit, and the
        Company will cause the other Consolidated Companies not to permit, 
        Short-Term Debt of the Consolidated Companies on a consolidated basis to
        exceed at any time an amount equal to $2,000,000; and for at least 30
        consecutive days during each Fiscal Year the Obligors will reduce, and
        the Company will cause the other Consolidated Companies to reduce, the
        aggregate outstanding principal amount of Short-Term Debt of the
        Consolidated Companies on a consolidated basis to zero.

                
                5.10  Section 7.22 of the Credit Agreement is hereby amended and
restated in full as follows:

                Section 7.22. Operating Lease Obligations. The Obligors will not
        create or incur, and the Company will not permit the other Consolidated
        Companies to create or incur, any obligations for the payment by the
        Consolidated Companies of rentals for any property under Operating
        Leases, except for Operating Leases


                                      10

<PAGE>
 
       which, together with all other Operating Leases of the Consolidated 
       Companies (including, without limitation, the Consolidated Companies
       existing Operating Leases with Capstone Capital Corporation and Charter
       Canyon Behavioral Health System, Inc.), provide for aggregate annual
       rental payments by the Consolidated Companies on a consolidated basis in
       the current or any future Fiscal Year not exceeding $5,000,000.

          5.11. Section 7.24 of the Credit Agreement is hereby amended and 
restated in full as follows:

               Section 7.24. Management Agreements. The Obligors will not pay, 
       and the Company will not permit any of the other Consolidated Companies
       to pay, any Ramsay Management Fees, except Ramsay Management Fees
       payable by the Company to any Paul Ramsay Affiliate pursuant to the
       Ramsay Management Agreement; provided that (i) the Company's obligation
       to pay Ramsay Management Fees shall be subordinate to all amounts now or
       hereafter owing by the Company to the Agent, the Issuing Bank of the
       Lenders under the Credit Documents, (ii) the Company's obligations to pay
       Ramsay Management Fees for services rendered during each Fiscal Year
       shall accrue and may be paid in common stock of the Company at any time,
       but shall not be paid in cash or other property (except such common
       stock) until after the close of such Fiscal Year, and then such payment
       shall be permitted only if, with respect to the Company's Fiscal Year
       ending June 30, 1996, the Consolidated Companies' EBITDA for such Fiscal
       Year (as shown on the Consolidated Companies audited financial statements
       for such Fiscal Year furnished to the Agent pursuant to the Credit
       Agreement) is at least $17,800,000 (less amounts reasonably acceptable to
       the Lenders in its discretion to reflect the reduction in budgeted
       earning capacity in such Fiscal Year allocable to any operating assets
       disposed of prior to the close of such Fiscal Year), and with respect to
       each Fiscal Year thereafter, the Consolidated Companies' EBITDA for such
       Fiscal Year (as shown on the Consolidated Companies audited financial
       statements for such Fiscal Year furnished to the Agent pursuant to the
       Credit Agreement) is at least 90% of the Company's budget therefor as
       presented to the Lenders prior to September 15, 1995 or as thereafter
       presented to and approved by the Lenders at their discretion (less
       amounts reasonably acceptable to the Lenders in its discretion to reflect
       the reduction in budgeted earning capacity in such Fiscal Year allocable
       to any operating assets disposed of prior to the close of such Fiscal
       Year).

                                      11
<PAGE>
 
       The Company will cause Ramsay Health Care Pty. Ltd to execute and 
       deliver to the Agent and the Lenders on the Closing Date a Ramsay
       Management Fee Subordination Agreement (the "Ramsay Management Fee
       Subordination Agreement") pursuant to which Ramsay Health Care Pty. Ltd
       will subordinate all present and future claims to Ramsay Management Fees
       owing under the Ramsay Management Agreement (or any successor management
       agreement) to all amounts now or hereafter owing by any Obligor under the
       Credit Documents. The Company will not (i) amend, modify or supplement
       the Ramsay Management Agreement, other than one or more extensions of the
       term thereof on the same terms and conditions as are in effect on the
       Closing Date and other than an assignment thereof by a Paul Ramsay
       Affiliate to another Paul Ramsay Affiliate (in each case subject to the
       Ramsay Management Fee Subordination Agreement), (ii) enter into any other
       management agreement with Paul J. Ramsay or any Paul Ramsay Affiliate, or
       (iii) enter into any management agreement with any other Person (other
       than a Consolidated Company) with respect to the management by such
       Person of material operations of any Obligor or of the Consolidated
       Companies taken as a whole.

          5.12. Article VII of the Credit Agreement is hereby amended by adding 
the following Sections 7.33 and 7.34 to the end of such Article:

           Section 7.33. Limitation on Dividends and Purchases of Shares. The 
       Company will not pay dividends (other than dividends payable exclusively
       in common stock of the Company) on or purchase any shares of any class of
       its common or preferred stock, unless (i) with respect to dividends to
       be paid or shares to be purchased during the Company's fiscal ending June
       30, 1996, the Consolidated Companies' Maximum Annual Debt Service and
       Lease Payment Coverage Ratio for the Fiscal Year ended June 30, 1995 is
       more than 1.30 to 1 (as shown on the Consolidated Companies' audited
       financial statements for such Fiscal Year furnished to the Agent pursuant
       to the Credit Agreement), and with respect to dividends to be paid or
       shares to be purchased after June 30, 1996, the Consolidated Companies'
       Maximum Annual Debt Service and Lease Payment Coverage Ratio for the
       immediately preceding Fiscal Year of the Consolidated Companies is at
       least 1.50 to 1 (as shown on the Consolidated Companies' audited
       financial statements for such Fiscal Year furnished to the Agent pursuant
       to the Credit Agreement), (ii) no Default or Event of Default has

                                      12


<PAGE>
 
       occurred and is continuing or would occur as a result of such payment or 
       purchase, and (iii) the aggregate amount of any and all such dividends
       and purchases is less than 50% of the Net Income of the Consolidated
       Companies for the immediately preceding Fiscal Year of the Consolidated
       Companies (as shown on the Consolidated Companies' audited financial
       statements for such Fiscal Year furnished to the Agent pursuant to the
       Credit Agreement); provided that the payment of dividends by the Company
       of not more than $387,200 on the Company's Class B and Class C
       convertible preferred stock shall be permitted in any Fiscal Year as long
       as no Default or Event of Default has occurred and is continuing or would
       occur as a result of such payment.

             Section 7.34. Reduction of Maximum Credit Availability. The
       Borrowers will cause the Maximum Credit Availability to be reduced to not
       more than $20,308,364.72 by December 31, 1995, and to not more than
       $17,145,835.32 by July 1, 1996, through permanent reductions in the total
       of the Letter of Credit Amounts of the Letters of Credit as a result of
       mandatory sinking fund redemptions and/or optional redemptions of Bonds
       and/or through permanent reductions of the Revolving Credit Maximum
       Commitment Amount pursuant to Section 2.04(g).

           5.13. Section 8.01(c) of the Credit Agreement is hereby amended and 
restated in full as follows:

             (c) Failure by any Obligor to perform or comply with any of the 
       terms or conditions contained in Section 7.01, 7.07, 7.10, 7.13, 7.16,
       7.20, 7.21, 7.22, 7.24, 7.25, 7.26, 7.27, 7.29, 7.30, 7.33 or 7.34, or
       the Obligors shall grant or otherwise create any Lien or sale/lease-back
       transaction in violation of Section 7.14;

           5.14. The address as which notices and other communications are to be
sent to the Agent, the Issuing Bank or Societe Generale (in its capacity as a 
Lender) pursuant to Section 10.01 of the Credit Agreement is hereby changed to 
the following:

           Societe Generale, New York Branch
           1221 Avenue of the Americas, 7th Floor
           New York, NY 10020
           Attention:  Sedare Coradin
                       Vice President
                       Telephone:  (212) 278-6878
                       Telecopier: (212) 278-7430

                                      13
<PAGE>

 
           with a copy to:

           Societe Generale, New York Branch
           1221 Avenue of the Americas, 7th Floor
           New York, NY 10020
           Attention:  Jeffrey Green
                       Assistant Treasurer
                       Special Letter of Credit Services
                       Telephone:  (212) 278-6727
                       Telecopier: (212) 278-7428

           6. Conditions Precedent.  As conditions precedent to the Banks' 
execution and delivery of this Amendment, the Agent shall have received the 
following in form and substance satisfactory to the  Banks:

             (a) A certificate of the president, chief executive officer or
       chief financial officer of each Obligor as of the date of execution and
       delivery by the Obligors or this Amendment stating that (1) the
       representations and warranties contained in Section 7 of this Amendment
       are true and correct, (2) all obligations, covenants, agreements and
       conditions contained in the Agreement to be performed or satisfied by
       such Obligor on or prior to the date of execution and delivery by the
       Obligors of this Amendment have been performed or satisfied in all
       respects, (3) since June 30, 1995, there has been no material adverse
       change in the properties, business, operations, assets, condition
       (financial or otherwise) or prospects of such Obligor (or, in the case of
       the certificate of the respective officer of the Company, the
       Consolidated Companies taken as a whole) other than as disclosed in such
       certificate, and (4) after given effect to this Amendment, no Default or
       Event of Default has occurred and is continuing;

             (b) An opinion of Haythe & Curley, New York, New York, counsel to 
       the Obligors, to the effect that (1) the execution and delivery by the
       Obligors of this Amendment has been duly authorized by all requisite
       corporate action, (2) this Amendment has been duly executed and delivered
       by the Obligors and constitutes the legal, valid and binding obligation
       of the Obligors enforceable against the Obligors in accordance with its
       terms, except to the extent that the enforceability thereof may be
       limited by applicable bankruptcy, insolvency, reorganization, moratorium
       or other laws affecting the rights of creditors generally and by the
       application of general principles of equity, and (3) the execution and
       delivery of this Amendment does not conflict with or constitute a default
       under the Life Company Indenture or the Consolidated Companies' Operating
       Leases with Capstone Capital Corporation and Charter Canyon

                                      14

<PAGE>
 
    Behavioral Health System, Inc. or the Consolidated Companies have otherwise 
    obtained all requisite consents of the parties to such agreements in
    connection with this Amendment; and

      (c) Such other documents, certificates and opinions of counsel as the 
    Agent may reasonably request.

    7. Representations and Warranties. The Obligors hereby represent and warrant
that:

    (a) The representations and warranties made by the Obligors in the Credit 
Agreement and all documents delivered in connection therewith are true and
correct on and as of the date of execution and delivery by the Obligors of this
Amendment, except to the extent that such representations and warranties
expressly relate to an earlier date. After giving effect to this Amendment, no
Default or Event of Default has occurred and is continuing on the date of
execution and delivery by the Obligors of this Amendment.


    (b) This Amendment has been duly authorized by all requisite action on 
behalf of the Obligors and constitutes the legal, valid and binding obligation 
of the Obligors, enforceable in accordance with its terms, except as the same 
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium
or other laws or equitable principles affecting creditors' rights generally.

    (c) The Obligors have obtained all consents and approvals necessary to their
execution and delivery of this Amendment.

    8. Costs and Expenses. The Obligors hereby agree to pay on demand all costs 
and expenses of the Agent and the Issuing Bank in connection with the 
preparation, execution and delivery of this Amendment and the amendments 
extending the Letters of Credit being delivered pursuant to section 2 of this 
Amendment, including without limitation the reasonable fees and expenses of 
counsel for the Agent and the Issuing Bank with respect thereto.

    9. Counterparts. This Amendment may be executed in one or more counterparts 
each of which shall constitute an original Amendment and all of which together 
shall constitute one and the same Amendment.

    10. Effect. Upon the execution and delivery of this Amendment, the Credit 
Agreement shall be and be deemed to be amended as set forth in this Amendment. 
All of the provisions of the Credit Agreement shall remain in full force and 
effect as amended by the First Amendment and this Amendment.

                                      15
<PAGE>
 
    11. Governing Law. This Amendment shall be governed by, and construed in 
accordance with, the laws of the State of New York, without regard to principles
of conflicts of law. The foregoing choice of law is made pursuant to Section 
5-1401 of the General Obligations Law of the State of New York.

                                      16
<PAGE>
 
    IN WITNESS WHEREOF, the Obligors, the Lenders, the Issuing Bank and the 
Agent have caused this Agreement to be duly executed and delivered as of the 
date first above written.

[CORPORATE SEAL]                               RAMSAY HEALTH CARE, INC.
                                           
Attest  /s/ Daniel Sims                        By  /s/ Reynold Jennings
      ------------------------                   --------------------------
        Assistant Secretary                             President

                                           
[CORPORATE SEAL]                               GREENBRIER HOSPITAL, INC.
                                           
Attest  /s/ John Quinn                         By  /s/ Reynold Jennings
      ------------------------                   --------------------------
            Secretary                                    President

                                           
[CORPORATE SEAL]                               HOUMA PSYCHIATRIC HOSPITAL, INC.
                                           
Attest  /s/ John Quinn                         By  /s/ Reynold Jennings
      ------------------------                   --------------------------
            Secretary                                    President

                                           
[CORPORATE SEAL]                               HSA OF OKLAHOMA, INC.   
                                           
Attest  /s/ John Quinn                         By  /s/ Reynold Jennings
      ------------------------                   --------------------------
            Secretary                                    President


[CORPORATE SEAL]                               CAROLINA TREATMENT CENTER, INC.
                                           
Attest  /s/ John Quinn                         By  /s/ Reynold Jennings
      ------------------------                   --------------------------
            Secretary                                    President


This execution page is part of the Second Amendment dated as of September 15, 
1995 to the Credit Agreement dated as of May 15, 1993, among Ramsay Health Care,
Inc., Greenbrier Hospital, Inc., Houma Psychiatric Hospital, Inc., HSA of 
Oklahoma, Inc., Carolina Treatment Center, Inc., Gulf Coast Treatment Center, 
Inc. and Atlantic Treatment Center, Inc., as Borrowers, Great Plains Hospital, 
Inc. and The Haven Hospital, Inc., as Guarantors, Societe Generale, New York 
Branch, First Union National Bank of North Carolina and Hibernia National Bank, 
as Lenders, Societe Generale, as Issuing Bank, and Societe Generale, as Agent.

                                      17
<PAGE>
 
                                           
[CORPORATE SEAL]                               GULF COAST TREATMENT CENTER, INC.
                                           
Attest  /s/ John Quinn                         By  /s/ Reynold Jennings
      ------------------------                   --------------------------
            Secretary                                    President

                                           
[CORPORATE SEAL]                               ATLANTIC TREATMENT CENTER, INC. 
                                           
Attest  /s/ John Quinn                         By  /s/ Reynold Jennings
      ------------------------                   --------------------------
            Secretary                                    President

                                           
[CORPORATE SEAL]                               GREAT PLAINS HOSPITAL, INC.
                                           
Attest  /s/ John Quinn                         By  /s/ Reynold Jennings
      ------------------------                   --------------------------
            Secretary                                    President


[CORPORATE SEAL]                               THE HAVEN HOSPITAL, INC.
                                           
Attest  /s/ John Quinn                         By  /s/ Reynold Jennings
      ------------------------                   --------------------------
            Secretary                                    President


This execution page is part of the Second Amendment dated as of September 15, 
1995 to the Credit Agreement dated as of May 15, 1993, among Ramsay Health Care,
Inc., Greenbrier Hospital, Inc., Houma Psychiatric Hospital, Inc., HSA of 
Oklahoma, Inc., Carolina Treatment Center, Inc., Gulf Coast Treatment Center, 
Inc. and Atlantic Treatment Center, Inc., as Borrowers, Great Plains Hospital, 
Inc. and The Haven Hospital, Inc., as Guarantors, Societe Generale, New York 
Branch, First Union National Bank of North Carolina and Hibernia National Bank, 
as Lenders, Societe Generale, as Issuing Bank, and Societe Generale, as Agent.

                                      18

<PAGE>
 
                                        SOCIETE GENERALE, NEW YORK
                                          BRANCH, as Lender, Issuing
                                          Bank and Agent

                                        By  /s/ Sedare Coradin
                                          -------------------------------
                                        Title  Vice President
                                             ----------------------------

This execution page is part of the Second Amendment dated as of September 15, 
1995 to the Credit Agreement dated as of May 15, 1993, among Ramsay Health Care,
Inc., Greenbrier Hospital, Inc., Houma Psychiatric Hospital, Inc., HSA of
Oklahoma, Inc., Carolina Treatment Center, Inc., Gulf Coast Treatment Center,
Inc. and Atlantic Treatment Center, Inc., as Borrowers, Great Plains Hospital,
Inc. and The Haven Hospital, Inc., as Guarantors, Societe Generale, New York
Branch, First Union National Bank of North Carolina and HiberniaNational Bank,
as Lenders, Societe Generale, as Issuing Bank, and Societe Generale, as Agent.

                                      19
<PAGE>
 
 
                                        FIRST UNION BANK OF NORTH 
                                         CAROLINA, as Lender
         
                                        By: /s/ John Ransom
                                           -------------------------
                                        Title: Senior Vice President
                                              ----------------------

This execution page is part of the Second Amendment dated as of September 15, 
1995 to the Credit Agreement dated as of May 15, 1993, among Ramsay Health Care,
Inc., Greenbrier Hospital, Inc., Houma Psychiatric Hospital, Inc., HSA of
Oklahoma, Inc., Carolina Treatment Center, Inc., Gulf Coast Treatment Center,
Inc. and Atlantic Treatment Center, Inc., as Borrowers, Great Plains Hospital,
Inc. and The Haven Hospital, Inc., as Guarantors, Societe Generale, New York
Branch, First Union National Bank of North Carolina and Hibernia National Bank,
as Lenders, Societe Generale, as Issuing Bank, and Societe Generale, as Agent.

                                      20

<PAGE>
 
                                HIBERNIA NATIONAL BANK, as
                                 Lender

                                By:  /s/ Ross Wales
                                   -------------------------
                                Title:    Banking Officer
                                      ----------------------

This execution page is part of the Second Amendment dated as of September 15, 
1995 to the Credit Agreement dated as of May 15, 1993, among Ramsay Health Care,
Inc., Greenbrier Hospital, Inc., Houma Psychiatric Hospital, Inc., HSA of
Oklahoma, Inc., Carolina Treatment Center, Inc., Gulf Coast Treatment Center,
Inc. and Atlantic Treatment Center, Inc., as Borrowers, Great Plains Hospital,
Inc. and The Haven Hospital, Inc., as Guarantors, Societe Generale, New York
Branch, First Union National Bank of North Carolina and Hibernia National Bank,
as Lenders, Societe Generale, as Issuing Bank, and Societe Generale, as Agent.

                                      21

<PAGE>
 
                                                                  EXHIBIT 10.100

================================================================================



                      FOURTH SUPPLEMENTAL TRUST INDENTURE


                         Dated as of September 15, 1995


                                    Between

                           RAMSAY HEALTH CARE, INC.,
                     BOUNTIFUL PSYCHIATRIC HOSPITAL, INC.,
                        CUMBERLAND MENTAL HEALTH, INC.,
                EAST CAROLINA PSYCHIATRIC SERVICES CORPORATION,
                            HAVENWYCK HOSPITAL, INC.
                        MESA PSYCHIATRIC HOSPITAL, INC.

                                      and

                  PSYCHIATRIC INSTITUTE OF WEST VIRGINIA, INC.

                                      and

                  NATIONSBANK OF GEORGIA, NATIONAL ASSOCIATION

                                      and

                                ELIZABETH TALLEY


                                                                     As Trustees


================================================================================
<PAGE>
 

                               Table of Contents
                               -----------------


Section 1.  Definitions...................................................

     Section 1.1.   Definitions Contained in the Original Indenture.......

     Section 1.2.   Amendment of Certain Definitions Contained in 
                    the Original Indenture................................

     Section 1.3    New Definitions.......................................

Section 2.  Amendments....................................................

     Section 2.1.   Amendment of (S) 3.17 of the Original Indenture.......

     Section 2.2    Amendment of (S) 3.18 of the Original Indenture.......

Section 3.  Miscellaneous.................................................

     Section 3.1.   Applicability of the Original Indenture...............

     Section 3.2.   Counterparts..........................................

     Section 3.3.   No Legend Required....................................

     Section 3.4.   No Responsibility of Trustees for Recitals............

     Section 3.5.   Consent of Lenders to Supplement......................

     Section 3.6.   Furnishing of Documents...............................

     Section 3.7.   Payment of Special Counsel Fees.......................

     Section 3.8.   Payment of Administrative Fee.........................
<PAGE>
 

                      FOURTH SUPPLEMENTAL TRUST INDENTURE
                      -----------------------------------



          FOURTH SUPPLEMENTAL TRUST INDENTURE dated as of September 15, 1995
(herein called the "Supplement") between RAMSAY HEALTH CARE, INC., a Delaware
corporation (the "Company"), BOUNTIFUL PSYCHIATRIC HOSPITAL, INC., a Utah
corporation ("Bountiful Psychiatric"), CUMBERLAND MENTAL HEALTH, INC., a North
Carolina corporation ("Cumberland"), EAST CAROLINA PSYCHIATRIC SERVICES
CORPORATION, a North Carolina corporation ("East Carolina Psychiatric"),
HAVENWYCK HOSPITAL, INC., a Michigan corporation ("Havenwyck"), MESA PSYCHIATRIC
HOSPITAL, INC., an Arizona corporation ("Mesa Psychiatric"), and PSYCHIATRIC
INSTITUTE OF WEST VIRGINIA, INC., a Virginia corporation ("Psychiatric
Institute; together with the Company, Bountiful Psychiatric, Cumberland, East
Carolina Psychiatric, Havenwyck and Mesa Psychiatric collectively being
hereinafter referred to as the "Obligors"), whose post office addresses are One
Poydras Plaza, 639 Loyola Avenue, Suite 1700, New Orleans, Louisiana 70113, and
NATIONSBANK OF GEORGIA, NATIONAL ASSOCIATION (formerly The Citizens and Southern
National Bank), a national banking association (the "Trustee"), whose post
office address is 600 Peachtree Street, Suite 900, Atlanta Georgia 30308,
Attention: Corporate Trust Department and ELIZABETH TALLEY (the "Individual
Trustee"), whose post office address is 600 Peachtree Street, Suite 900,
Atlanta, Georgia 30308, as Trustees (the Trustee and the Individual Trustee
hereinafter collectively referred to as the "Trustees").

          WHEREAS, the Obligors on April 30, 1990 issued their 11.6% Senior
Secured Notes due March 31, 2000 in the aggregate principal amount of
$56,500,000 (the "Senior Notes") and their 15.6% Subordinated Secured Notes due
March 31, 2000 in the aggregate principal amount of $3,000,000 (the
"Subordinated Notes"; and the Senior Notes and Subordinated Notes collectively,
the "Notes") under and secured by the Trust Indenture dated as of March 31, 1990
from the Obligors to the Trustees (the "First Indenture"); and

          WHEREAS, the Obligors and the Trustees entered into a First
Supplemental Trust Indenture dated as of June 15, 1991 (the "First Supplemental
Indenture"), entered into a Second Supplemental Trust Indenture dated as of May
15, 1993 (the "Second Supplemental Indenture") and entered into a Third
Supplemental Trust Indenture dated as of April 12, 1995 (the "Third Supplemental
Indenture"; and the
<PAGE>
 
                                                                             2

First Indenture as amended by the First Supplemental Indenture, the Second
Supplemental Indenture and the Third Supplemental Indenture (the "Original
Indenture"), and as hereby amended and as the same may be further amended and
supplemented from time to time being referred to as the "Indenture"); and

          WHEREAS, the Obligors have requested the holders of the Senior Notes
and the Subordinated Notes to consent to certain amendments to the Indenture and
the holders of all of the Notes outstanding have consented in writing to such
changes and all other matters set forth in or effectuated by this Supplement;
and

          WHEREAS, all things necessary to make this Supplement the valid
obligation of the Obligors according to its tenor and effect have been done or
authorized;

          NOW, THEREFORE, in consideration of the premises and of the sum of Ten
Dollars and of other good and valuable consideration, receipt whereof upon the
delivery of this Supplement the Obligors hereby acknowledge, and in order to
strengthen the financial and operating condition of each and every Obligor,
directly or indirectly, as a result of the enhanced ability of the Company to
provide financial, accounting, consulting and administrative assistance and
services to each other Obligor, and in order to secure the payment, subject to
(S) 10 of the Indenture, of both the principal of and interest and premium, if
any, on the Notes at any time outstanding thereunder according to their tenor
and the provisions thereof, and, further subject to (S) 10 of the Indenture, to
secure the faithful performance and observance of all the covenants and
provisions in the Notes, the Note Agreements, the Pledge Agreements, the
Mortgages and in the Indenture contained, the Obligors hereby covenant and agree
with the Trustees for the equal and pro rata benefit of all present and future
holders of all Notes issued under the Indenture, subject to (S) 10 of the
Indenture, without any preference, priority or distinction as follows:

     Section 1.  Definitions.

          Section 1.1.  Definitions Contained in the Original Indenture.  Except
as otherwise provided in Section 1.2 of this Supplement, words and phrases
defined in the Original Indenture shall have the same meanings ascribed to them
therein when used herein, unless the context or use indicates a different
meaning or intent.
<PAGE>
 
                                                                               3

          Section 1.2.  Amendment of Certain Definitions Contained in the
Original Indenture.  Unless the context otherwise requires, the following
definitions contained in Section (S) 1.1 of the Original Indenture are hereby
amended in their entirely as follows:

          "'Bank Debt' shall mean (i) indebtedness for borrowed money
outstanding under the working capital facility provided under the Credit
Agreement and referred to therein as the 'Revolving Credit Loans' in an
aggregate principal amount not to exceed $2,000,000, (ii) indebtedness
outstanding under the letter of credit facility provided under the Credit
Agreement in an aggregate amount not to exceed $21,041,109.29 and referred to
therein as the 'Letters of Credit' and (iii) indebtedness outstanding under the
term loan facility provided under the Credit Agreement upon termination of the
Letters of Credit referred to in (ii) above in an aggregate principal amount not
to exceed $20,100,000 and referred to therein as the 'Term Loans'".

          "'Credit Agreement' shall mean the Credit Agreement dated as of May
15, 1993, as amended as of April 12, 1995 and as of September 15, 1995, among
the Company and certain Subsidiaries, as the Borrowers, Great Plains Hospital,
Inc., and The Haven Hospital, Inc., as the Guarantors, Societe Generale, New
York Branch, First Union National Bank of North Carolina and Hibernia National
Bank, as lenders, and Societe Generale, New York Branch, as Issuing Bank and
Agent."

          "'Funded Indebtedness' of any Person shall mean and include without
duplication,

          (i) any obligation payable more than one year from the date of
creation thereof, which under generally accepted accounting principles is shown
on the balance sheet as a liability (including Capitalized Lease obligations but
excluding reserves for deferred income taxes and other reserves to the extent
that such reserves do not constitute an obligation),

          (ii) indebtedness payable more than one year from the date of creation
thereof which is secured by any Lien on, or payable out of the proceeds of
production from, property owned by the Company or any Subsidiary, whether or not
the indebtedness secured thereby shall have been assumed by the Company or such
Subsidiary,

          (iii) contingent obligations in respect of letters of credit issued
and not yet drawn upon,
<PAGE>
 
                                                                               4

          (iv) all Guaranties by such Person of Funded Indebtedness of others,
PROVIDED that if the indebtedness so guaranteed is also included in consolidated
Funded Indebtedness of such Person, the amount of such Guaranty shall not be
included as additional Funded Indebtedness,

          (v) obligations under any contract providing for the making of loans,
advances or capital contributions to any other Person, or for the purchase of
any property from any Person, in each case in order to enable such Person
primarily to maintain working capital, net worth or any other balance sheet
condition or to pay debts, dividends or expenses,

          (vi) obligations under any contract for the purchase of materials,
supplies or other property or services if such contract (or any related
document) requires that payment for such materials, supplies or other property
or services shall be made regardless of whether or not delivery of such
materials, supplies or other property or services is ever made or tendered,

          (vii) obligations under any Capitalized Lease or contract to rent or
lease (as lessee) any real or personal property if such contract (or any related
document) provides that the obligation to make payments thereunder is absolute
and unconditional under conditions not customarily found in commercial leases or
requires that the lessee purchase or otherwise acquire securities or obligations
of the lessor,

          (viii) obligations under any contract for the sale or use of
materials, supplies or other property or services if such contract (or any
related document) requires that payment for such materials, supplies or other
property or services, or the use thereof, shall be subordinated to any
indebtedness (of the purchaser or user of such materials, supplies or other
property or the Person entitled to the benefit of such services) owed or to be
owed to any Person,

          (ix) obligations under any other contract which, in economic effect,
is substantially equivalent to a guarantee, and

          (x) all capital stock of Subsidiaries of such Person which has a
preference as to dividends or upon liquidation and which is not owned by such
Person, either directly or through Subsidiaries of such Person,

          all as determined in accordance with generally accepted accounting
principles. Notwithstanding anything herein to the contrary, 'FUNDED
INDEBTEDNESS' of the Company
<PAGE>
 
                                                                               5

or any Consolidated Subsidiary shall not include (i) Subordinated Funded
Indebtedness, (ii) indebtedness outstanding under the working capital facility
of the Credit Agreement in a principal amount not to exceed $2,000,000 or (iii)
Practice Guaranties.  'CONSOLIDATED' when used as a prefix to any Funded
Indebtedness shall mean the aggregate amount of all such Funded Indebtedness of
the Company and its Consolidated Subsidiaries on a consolidated basis
eliminating intercompany items."

          "'Superior Indebtedness' shall mean (i) all obligations, liabilities
and indebtedness of the Obligors to the holders of the Senior Secured Notes in
an aggregate principal amount not to exceed $56,500,000 arising under the Senior
Secured Notes, the Note Purchase Agreements and this Indenture, (ii) all
obligations, liabilities and indebtedness in an aggregate amount not to exceed
$21,041,109.29 created or arising under certain industrial development bonds of
the Company or its Subsidiaries and associated letters of credit and
reimbursement obligations in connection therewith under the Credit Agreement
(including extensions, renewals and refundings thereof without increase in the
outstanding principal amount under such facility at such time), (iii) all
obligations, liabilities and indebtedness outstanding under the Credit Agreement
in an aggregate principal amount not to exceed $2,000,000 arising under the
"Revolving Loan Commitment" provided in the Credit Agreement (including
extensions, renewals and refundings thereof without increase in the outstanding
principal amount under such facility at such time), (iv) all obligations,
liabilities and indebtedness outstanding under the Credit Agreement arising
under the "Term Loans" provided in the Credit Agreement in an aggregate
principal amount not to exceed $20,100,000 (including extensions, renewals and
refundings thereof without increase in the outstanding principal amount under
such facility at such time), and (v) additional indebtedness incurred after the
date of the Original Indenture in an aggregate principal amount not to exceed
$25,000,000, PROVIDED that all proceeds of such additional indebtedness are used
exclusively to finance the acquisition, construction or renovation of facilities
owned or acquired by the Company or any Subsidiary.  Interest accrued on the
indebtedness described in the foregoing clauses (i), (ii), (iii), (iv) and (v)
shall constitute "Superior Indebtedness" regardless of whether such interest
accrues before or after the commencement of any bankruptcy, insolvency or
receivership proceedings."
<PAGE>
 
                                                                               6

     Section 1.3.  New Definitions.  Unless the context otherwise requires, the
terms hereinafter set forth when used herein in the Indenture shall have the
following meanings and the following definitions shall be equally applicable to
both the singular and plural forms of any of the terms herein defined:

          "'Fourth Supplemental Indenture' shall mean the Fourth Supplemental
Trust Indenture dated as of September 15, 1995 between the Obligors and the
Trustees."

     Section 2.  Amendments.

     Section 2.1.  Amendment of (S) 3.17 of the Original Indenture.  (S) 3.17 of
the Original Indenture is hereby amended in its entirety as follows:

          "SECTION 3.17.  FIXED CHARGE COVERAGE.  The Company will, as of the
     end of each fiscal quarter, keep and maintain the ratio of (i) the sum of
     (A) Consolidated Cash Flow plus (B) Rentals to (ii) Fixed Charges for the
     most recent four fiscal quarters, at not less than (x) 1.5 to 1, in the
     case of any determination being made hereunder on or prior to December 31,
     1995, (y) 1.75 to 1, in the case of any determination being made as of the
     end of the fiscal quarter ending March 31, 1996, and (z) 2.0 to 1, in the
     case of any determination being made hereunder at any time after March 31,
     1996."


          Section 2.2.  Amendment of (S) 3.18 of the Original Indenture.  (S)
3.18 of the Original Indenture shall be amended as follows:

          (a)  (S) 3.18(A)(2) of the Original Indenture is hereby amended in its
entirety as follows:

               "(2) the Bank Debt, PROVIDED that during the twelve-month period
          prior to May 15, 1993, there shall have been a period of 45
          consecutive days during which the Company and each of its Consolidated
          Subsidiaries shall have been free of all Indebtedness outstanding
          under the working capital facility of the Old Credit Agreement,
          FURTHER PROVIDED that during the twelve-month period immediately
          preceding the date of any determination hereunder occurring on or
          after May 15, 1994 and prior to September 15, 1995, there shall have
          been a period of 45 consecutive days during which the Company and each
          of its
<PAGE>
 
                                                                               7

          Consolidated Subsidiaries shall have been free of Indebtedness
          outstanding under the "Revolving Credit Loans" facility of the Credit
          Agreement in an amount equal to at least 75% of the "Revolving Credit
          Maximum Commitment Amount" (as such term is defined in the Credit
          Agreement as originally executed), and FURTHER PROVIDED that during
          the twelve-month period immediately preceding the date of any
          determination hereunder occurring on or after September 15, 1995,
          there shall have been a period of 30 consecutive days during which the
          Company and each of its Consolidated Subsidiaries shall have been free
          of Indebtedness outstanding under the "Revolving Credit Loans"
          facility of the Credit Agreement;"

          (b)  (S) 3.18(A)(4) of the Original Indenture is hereby amended in its
entirety as follows:

               "(4) Funded Indebtedness issued or incurred for the purpose of
          extending, renewing or refinancing (y) Funded Indebtedness outstanding
          as of the date of execution and delivery of the Fourth Supplemental
          Indenture and (z) that portion of the Bank Debt constituting Funded
          Indebtedness issued or incurred from time to time under the Credit
          Agreement, PROVIDED that in either case the principal amount of Funded
          Indebtedness extended, renewed or refinanced does not exceed the
          principal amount of such Funded Indebtedness outstanding immediately
          preceding such extension, renewal or refinancing;"

          (c) (S) 3.18(A)(7) of the Original Indenture is hereby amended in its
entirety as follows:

               "(7) unsecured Current Indebtedness of the Company and its
          Consolidated Subsidiaries, PROVIDED that during the twelve-month
          period prior to May 15, 1993, there shall have been a period of 45
          consecutive days during which the Company and each of its Consolidated
          Subsidiaries shall have been free of (x) all Indebtedness outstanding
          under the working capital facility of the Old Credit Agreement and (y)
          all other Current Indebtedness, PROVIDED FURTHER that during the
          twelve-month period immediately preceding the date of any
          determination hereunder occurring on or after May 15, 1994 and prior
          to September 15, 1995, there shall have been a period of 45
          consecutive days during which the Company and each
<PAGE>
 
                                                                               8

          of its Consolidated Subsidiaries shall have been free of (x)
          Indebtedness outstanding under the "Revolving Credit Loans" facility
          of the Credit Agreement in an amount equal to at least 75% of the
          "Revolving Loan Maximum Commitment Amount" (as such term is defined in
          the Credit Agreement as originally executed) and (y) all other Current
          Indebtedness, and PROVIDED FURTHER that during the twelve-month period
          immediately preceding the date of any determination hereunder
          occurring on or after September 15, 1995, there shall have been a
          period of 30 consecutive days during which the Company and each of its
          Consolidated Subsidiaries shall have been free of (x) Indebtedness
          outstanding under the "Revolving Credit Loans" facility of the Credit
          Agreement and (y) all other Current Indebtedness;"

          (d)  (S) 3.18(A)(15) of the Original Indenture is hereby amended in
its entirety as follows:

               "(15) additional Current Indebtedness incurred under the
          "Revolving Credit Loans" facility of the Credit Agreement in an
          aggregate principal amount not to exceed $2,000,000, PROVIDED that, at
          the time of the issuance or incurrence thereof and after giving effect
          thereto and to the application of the proceeds thereof:

                    (i) Consolidated Funded Indebtedness shall not exceed the
               following percentages of Total Capitalization:

                                           PERCENTAGE
                                            OF TOTAL
                    PERIOD               CAPITALIZATION

          July 1, 1992 thru June 30, 1993       69%

          July 1, 1993 and thereafter           65%

                    (ii) the ratio of Consolidated Funded Indebtedness to
               Consolidated Cash Flow for the most recent four fiscal quarters
               shall not exceed 4.0 to 1;

                    (iii) the sum of Consolidated Cash Flow plus Rentals for the
               most recent four fiscal quarters shall be not less than 1.5 times
               proforma Consolidated Debt Service for the immediately succeeding
               four fiscal quarters; and
<PAGE>
 
                                                                               9

                    (iv) No Default or Event of Default shall have occurred and
               be continuing;

PROVIDED FURTHER that during the twelve-month period immediately preceding the
date of any determination hereunder occurring on or after May 15, 1994 and prior
to September 15, 1995, there shall have been a period of 45 consecutive days
during which the Company and each of its Consolidated Subsidiaries shall have
been free of (x) Indebtedness outstanding under the "Revolving Credit Loans"
facility of the Credit Agreement in an amount equal to at least 75% of the
"Revolving Credit Maximum Commitment Amount" (as such term is defined in the
Credit Agreement as originally executed) and (y) all other Current Indebtedness,
and PROVIDED FURTHER that during the twelve-month period immediately preceding
the date of any determination hereunder occurring on or after September 15,
1995, there shall have been a period of 30 consecutive days during which the
Company and each of its Consolidated Subsidiaries shall have been free of (x)
Indebtedness outstanding under the "Revolving Credit Loans" facility of the
Credit Agreement and (y) all other Current Indebtedness."

     Section 3.  Miscellaneous.

          Section 3.1.  Applicability of the Original Indenture.  The provisions
of the Original Indenture, as supplemented and amended by this Supplement, are
hereby ratified, approved and confirmed and remain in full force and effect.
This Supplement shall be construed as having been authorized, executed and
delivered under the provisions of (S) 8.2 of the Indenture.

          Section 3.2.  Counterparts.  This Supplement may be simultaneously
executed in several counterparts, each of which shall be an original and all of
which shall constitute but one and the same instrument.

          Section 3.3.  No Legend Required.  Any and all notices, requests,
certificates and any other instruments, including the Notes may refer to the
Indenture or the Trust Indenture dated as of March 31, 1990, without making
specific reference to this Supplement, but nevertheless all such references
shall be deemed to include this Supplement unless the context shall otherwise
require.

          Section 3.4.  No Responsibility of Trustees for Recitals.  The
recitals and statements contained in this Supplement shall be taken as the
recitals and statements of the Obligors, and the Trustees assume no
responsibility for the correctness of the same.
<PAGE>
 
                                                                              10

          Section 3.5.  Consent of Lenders to Supplement.  The Company
represents and covenants that it has obtained the written consent of the
Requisite Lenders (as defined in the Credit Agreement) to its execution of this
Supplement.

          Section 3.6.  Furnishing of Documents.  The Company will within 10
business days after the date of the closing of the Second Amendment dated as of
September 15, 1995 (the "Bank Amendment") to the Credit Agreement (as defined in
the Indenture), furnish to each holder of the Notes, the Trustee and Chapman and
Cutler (a) fully executed counterparts of this Supplement and (b) the Bank
Amendment.

          Section 3.7.  Payment of Special Counsel Fees.  The Company will pay
within 30 days after receipt of a statement therefor, the reasonable fees and
disbursements of Chapman and Cutler as special counsel to the Noteholders in
connection with the execution and delivery of this Supplement.

          Section 3.8.  Payment of Administrative Fee. The Company has paid to
the Trustee for the ratable benefit of the Holders of the Senior Notes an
administrative fee in the aggregate amount of $60,000.


                            *          *          *
<PAGE>
 




          IN WITNESS WHEREOF, each Obligor has caused this Supplement to be
executed on its behalf by its President or Vice President and Vice President or
Secretary or Assistant Secretary; and NationsBank of Georgia, National
Association has caused this Supplement to be executed on its behalf by one of
its Corporate Trust Officers and attested by one of its Assistant Secretaries
and Elizabeth Talley has hereunto set her hand, all as of the date first above
written.

                              RAMSAY HEALTH CARE, INC.


                              By /S/ Reynold J. Jennings
                                ____________________________
                                Name:  Reynold J. Jennings
                                Title: President
ATTEST:

/S/ Daniel A. Sims
_________________________
Name:  Daniel A. Sims
Title: Assistant Secretary

                              BOUNTIFUL PSYCHIATRIC
                              HOSPITAL, INC.


                              By /S/ Reynold J. Jennings
                                ____________________________
                                Name:  Reynold J. Jennings
                                Title: President
ATTEST:

/S/ Daniel A. Sims
_________________________
Name:  Daniel A. Sims
Title: Assistant Secretary

                              CUMBERLAND MENTAL HEALTH, INC.


                              By /S/ Reynold J. Jennings
                                ____________________________
                                Name:  Reynold J. Jennings
                                Title: President
ATTEST:

/S/ Daniel A. Sims
_________________________
Name:  Daniel A. Sims
Title: Assistant Secretary
<PAGE>
 



                              EAST CAROLINA PSYCHIATRIC
                              SERVICES CORPORATION


                              By /S/ Reynold J. Jennings
                                ____________________________
                                Name:  Reynold J. Jennings
                                Title: President
ATTEST:

/S/ Daniel A. Sims
_________________________
Name:  Daniel A. Sims
Title: Assistant Secretary

                              HAVENWYCK HOSPITAL, INC.


                              By /S/ Reynold J. Jennings
                                ____________________________
                                Name:  Reynold J. Jennings
                                Title: President
ATTEST:

/S/ Daniel A. Sims
_________________________
Name:  Daniel A. Sims
Title: Assistant Secretary

                              MESA PSYCHIATRIC HOSPITAL, INC.


                              By /S/ Reynold J. Jennings
                                ____________________________
                                Name:  Reynold J. Jennings
                                Title: President
ATTEST:

/S/ Daniel A. Sims
_________________________
Name:  Daniel A. Sims
Title: Assistant Secretary

                              PSYCHIATRIC INSTITUTE OF 
                              WEST VIRGINIA, INC.


                              By /S/ Reynold J. Jennings
                                ____________________________
                                Name:  Reynold J. Jennings
                                Title: President
ATTEST:

/S/ Daniel A. Sims
______________________
Name:  Daniel A. Sims
Title: Assistant Secretary
<PAGE>
 




                              NATIONSBANK OF GEORGIA, 
                              NATIONAL ASSOCIATION, 
                              As Corporate Trustee


(SEAL)                        By /S/ Elizabeth T. Talley
                                ____________________________
                                Name:  Elizabeth T. Talley
                                Title: Asst. Vice President

ATTEST:

/S/ Sabrina Fuller
_________________________
Name:  Sabrina Fuller
Title: Trust Officer


                               /S/ Elizabeth T. Talley
                              ______________________________
                                    Elizabeth T. Talley,
                                    As Individual Trustee

<PAGE>
 
                                                                  EXHIBIT 10.101

                 AMENDED AND RESTATED STOCK PURCHASE AGREEMENT
                 ---------------------------------------------


     AMENDED AND RESTATED STOCK PURCHASE AGREEMENT dated as of October 12, 1995
by and among Paul Ramsay Holdings Pty. Limited, an Australian corporation (the
"Acquiror"), Ramsay Health Care, Inc., a Delaware corporation (the "Seller"),
and, solely for the purposes of Sections I, III and VI hereof, Ramsay Health
Care Pty. Limited, an Australian corporation (the "Manager").

                              W I T N E S S E T H:
                              ------------------- 

     WHEREAS, the Acquiror and the Seller are parties to that certain Stock
Purchase Agreement dated as of September 7, 1995 (the "Original Agreement")
pursuant to which the Acquiror is to purchase 266,667 shares of common stock,
$.01 par value ("Common Stock"), of the Seller (the "Original Shares"), and the
Seller is to issue and sell to the Acquiror, for the consideration therein
provided, the Original Shares;

     WHEREAS, the Seller is unable to comply with the conditions to the
Acquiror's obligation to close set forth in Section V(D) of the Original
Agreement;

     WHEREAS, the Manager is an affiliate of the Acquiror and a party to that
certain Amended and Restated Management Agreement dated as of June 25, 1992 with
the Seller (the "Management Agreement") pursuant to which the Seller, among
other matters, is obligated to pay certain management fees and other amounts to
the Manager;

     WHEREAS, the Seller proposes to enter into an agreement with certain of its
lenders which would restrict the payment in cash of the amounts now and
hereafter due pursuant to the Management Agreement;

     WHEREAS, the Seller, the Acquiror and the Manager desire to provide for the
issuance of 154,500 shares of Common Stock (the "Management Fee Shares") for a
purchase price of $560,062.50 payable $1,545.00 in cash and as a prepayment by
the Seller of $558,517.50 in Management Fees;

     WHEREAS, the Acquiror desires to purchase an additional 121,363 shares of
Common Stock (the "Cash Shares", and together with the Management Fee Shares,
the "Shares") for $439,940.88 in cash; and
<PAGE>
 
                                                                               2

     WHEREAS, the Acquiror and the Seller have determined that it is desirable
to amend and restate the Original Agreement to delete Section V(D) of the
Original Agreement to provide for the purchase and sale of the Shares in lieu of
the Original Shares as set forth herein;

     NOW, THEREFORE, in consideration of the premises and the mutual covenants
and agreements hereinafter set forth, the parties hereto hereby agree as
follows:
                                   SECTION I

                        PURCHASE AND SALE OF THE SHARES
                        -------------------------------

     A.  Purchase and Sale of the Shares.  Subject to the terms and conditions
of this Agreement and on the basis of the representations, warranties, covenants
and agreements herein contained, (i) the Seller hereby agrees to sell, issue and
convey to the Acquiror on the Closing Date (as hereinafter defined), and the
Acquiror hereby agrees to purchase, acquire and accept from the Seller on the
Closing Date, the Cash Shares, and (ii) the Manager hereby directs the Seller
to, the Seller does hereby, issue and convey to the Acquiror on the date hereof,
and the Acquiror hereby acquires and accepts from the Seller on the date hereof,
the Management Fee Shares.

     B.  Consideration for the Shares.  The consideration for the issuance of
the Shares shall be paid as follows:

          (i) The Management Fee Shares are being issued for a purchase price of
$560,062.50 payable $1,545.00 in cash and as a prepayment by the Seller of
$558,517.50 of amounts now and hereafter due during the Seller's current fiscal
year pursuant to the Management Agreement, representing a purchase price of
$3.625 per share of Common Stock.  The Manager hereby accepts the issuance by
the Seller to the Acquiror of the Management Fee Shares as a prepayment of
$558,517.50 of the amounts now or hereafter due during the Seller's current
fiscal year pursuant to the Management Agreement.  The Seller hereby
acknowledges receipt of $1,545.00 in cash from the Manager in payment of the
cash portion of the purchase price for the Management Fee Shares.

          (ii) The Acquiror hereby agrees, subject to and in accordance with the
terms and conditions hereof, to pay to the Seller on the Closing Date, upon
receipt of the certificate for the Cash Shares referred to in paragraph C
<PAGE>
 
                                                                               3

of this Section I, the sum of $439,940.88, representing a purchase price of
$3.625 per share of Common Stock, payable in cash by certified or official bank
check payable to the order of the Seller or direct bank wire transfer of
immediately available funds to a bank account or accounts to be designated by
the Seller.

          C.  Delivery of the Shares.  The Acquiror hereby acknowledges receipt
of a certificate of the Seller representing the Management Fee Shares.  Delivery
of the Cash Shares shall be made by the Seller to the Acquiror on the Closing
Date by delivering a certificate of the Seller representing the Cash Shares
registered in the name of the Acquiror, such certificate to be accompanied by
any requisite documentary or stock transfer taxes.

          D.  The Closing.  The closing of the sale of the Cash Shares to the
Acquiror shall occur on October 30, 1995 (the "Closing Date"), or on such other
date as shall be mutually agreed to between the Seller and the Acquiror.

                                  SECTION II

                        REPRESENTATIONS AND WARRANTIES
                                 OF THE SELLER
                        ------------------------------

          The Seller hereby represents and warrants to the Acquiror and the
Manager, as of the date hereof and as of the Closing Date, that:

          A.  Organization; Good Standing.  The Seller is a corporation duly
organized, validly existing and in good standing under the laws of its
jurisdiction of incorporation and has full corporate power and authority to own
its properties and to conduct the businesses in which it is now engaged.

          B.  Authority.  The Seller has full corporate power and authority to
execute and deliver this Agreement and to perform all of its obligations
hereunder, and no consent or approval of any other person or governmental
authority is required therefor.  The execution and delivery of this Agreement by
the Seller, the performance by the Seller of its covenants and agreements
hereunder and the consummation by the Seller of the transactions contemplated
hereby have been duly authorized by all necessary corporate action.  This
Agreement constitutes a valid and legally binding obligation of the Seller,
enforceable against the Seller in accordance with its terms, except as such
enforceability may be limited by bankruptcy, insolvency or
<PAGE>
 
                                                                               4

other similar laws of general application relating to or affecting the
enforcement of creditors' rights or by general principles of equity.

          C.  No Legal Bar; Conflicts.  Neither the execution and delivery of
this Agreement, nor the consummation of the transactions contemplated hereby,
violates any provision of the Certificate of Incorporation or By-Laws of the
Seller or any law, statute, ordinance, regulation, order, judgment or decree of
any court or governmental agency, or conflicts with or results in any breach of
any of the terms of or constitutes a default under or results in the termination
of or the creation of any lien pursuant to the terms of any contract or
agreement to which the Seller is a party or by which the Seller or any of its
assets is bound.

          D.  Authorization of Shares.  The Shares being purchased by the
Acquiror hereunder have been duly and validly authorized and, upon delivery of
the certificate representing ownership by the Acquiror of the Shares as herein
provided, for the consideration herein provided, such Shares will be duly and
validly issued, fully paid and nonassessable.

                                  SECTION III

                        REPRESENTATIONS AND WARRANTIES
                        OF THE ACQUIROR AND THE MANAGER
                        -------------------------------

          Each of the Acquiror and the Manager, jointly and severally, hereby
represents and warrants to the Seller, as of the date hereof and as of the
Closing Date, that:

          A.  Authority.  It has full corporate power and authority to execute
and deliver this Agreement and to perform all of its obligations hereunder, and
no consent or approval of any other person or governmental authority is required
therefor.  The execution and delivery of this Agreement by it, the performance
by it of its covenants and agreements hereunder and the consummation by it of
the transactions contemplated hereby have been duly authorized by all necessary
corporate action.  This Agreement constitutes a valid and legally binding
obligation of it, enforceable against it in accordance with its terms, except as
such enforceability may be limited by bankruptcy, insolvency or other similar
laws of general application relating to or affecting the enforcement of
creditors' rights or by general principles of equity.
<PAGE>
 
                                                                               5

          B.  No Legal Bar; Conflicts.  Neither the execution and delivery of
this Agreement, nor the consummation of the transactions contemplated hereby,
violates any law, statute, ordinance, regulation, order, judgment or decree of
any court or governmental agency, or conflicts with or results in any breach of
any of the terms of or constitutes a default under or results in the termination
of or the creation of any lien pursuant to the terms of any contract or
agreement to which it is a party or by which it or any of its assets is bound.

          C.  Investment in the Seller.

          (i) It understands that the Seller proposes to issue and deliver to
the Acquiror the Shares pursuant to this Agreement without compliance with the
registration requirements of the Securities Act of 1933, as amended (the
"Securities Act"); that for such purpose the Seller will rely upon its
representations and warranties contained herein; and that such non-compliance
with registration is not permissible unless such representations and warranties
are correct.

          (ii) It understands that, under existing rules of the Securities and
Exchange Commission (the "SEC"), the Acquiror may be unable to sell the Shares
except to the extent that the Shares may be sold (i) pursuant to an effective
registration statement covering such sale pursuant to the Securities Act and
applicable state securities laws or an applicable exemption therefrom or (ii) in
a bona fide private placement to a purchaser who shall be subject to the same
restrictions on any resale or (iii) subject to the restrictions contained in
Rule 144 under the Securities Act ("Rule 144").

          (iii) It is not relying on the Seller respecting the financial, tax
and other economic considerations of an investment in the Common Stock, and it
has relied on the advice of, or has consulted with, only its own advisors.

          (iv) It is familiar with the provisions of Rule 144 and the
limitations upon the availability and applicability of such rule.

          (v) It is a sophisticated investor familiar with the type of risks
inherent in the acquisition of restricted securities such as the Shares and its
financial position is such that it can afford to retain the Shares for an
indefinite period of time without realizing any direct or indirect cash return
on its investment.
<PAGE>
 
                                                                               6

          (vi) It has such knowledge and experience in financial, tax and
business matters so as to enable it to utilize the information made available to
it in connection with the issuance of the Shares to the Acquiror and to evaluate
the merits and risks of an investment in the Shares and to make an informed
investment decision with respect thereto.

          (vii) The Acquiror is purchasing the Shares as an investment for its
sole account, and without any present view towards the resale or other
distribution thereof.

          D.  Legend.  Each certificate representing Shares shall contain upon
its face or upon the reverse side thereof a legend to the following effect:

     "These securities have not been registered under the Securities Act of
     1933, as amended, or qualified under state securities laws and may not be
     sold, pledged, or otherwise transferred unless (a) covered by an effective
     registration statement under the Securities Act of 1933, as amended, and
     qualified under applicable state securities laws, or (b) the Corporation
     has been furnished with an opinion of counsel acceptable to the Corporation
     to the effect that no registration or qualification is legally required for
     such transfer."

                                   SECTION IV

                 CONDITIONS TO THE SELLER'S OBLIGATION TO CLOSE
                 ----------------------------------------------

          The obligation of the Seller to sell the Cash Shares and otherwise to
consummate the transactions contemplated by this Agreement on the Closing Date
is subject to the following conditions precedent, any or all of which may be
waived by the Seller in the Seller's sole discretion, and each of which the
Acquiror hereby agrees to use its reasonable best efforts to satisfy at or prior
to the Closing:

          A.   Representations, Warranties and Covenants.  The representations
and warranties of the Acquiror contained herein shall be true and correct at and
as of the Closing Date with the same effect as though all such representations
and warranties were made at and as of the Closing Date and the Acquiror shall
have complied with all of its covenants and agreements contained herein required
to be complied with on or prior to the Closing Date.
<PAGE>
 
                                                                               7

          B.  No Litigation.  No action, suit, proceeding, writ, judgment,
injunction, decree or similar order of any governmental entity, authority or
agency or of any other third party restraining, enjoining or otherwise
preventing the consummation of any of the transactions contemplated by this
Agreement, or seeking to obtain any damages or any other relief as a result of
this Agreement or any of the transactions contemplated hereby, shall be pending
or threatened.

          C.   Approvals.  All governmental, corporate and other third party
filings, consents, authorizations and approvals (if any) that are required for
the consummation of the transactions contemplated hereby shall have been duly
made and obtained in form and substance reasonably satisfactory to the Seller.

                                   SECTION V

                CONDITIONS TO THE ACQUIROR'S OBLIGATION TO CLOSE
                ------------------------------------------------

          The obligation of the Acquiror to purchase the Cash Shares and
otherwise to consummate the transactions contemplated by this Agreement on the
Closing Date is subject to the following conditions precedent, any or all of
which may be waived by the Acquiror in its sole discretion, and each of which
the Seller hereby agrees to use its reasonable best efforts to satisfy at or
prior to the Closing:


          A.   Representations, Warranties and Covenants.  The representations
and warranties of the Seller contained herein shall be true and correct at and
as of the Closing Date with the same effect as though all such representations
and warranties were made at and as of the Closing Date and the Seller shall have
complied with all of its covenants and agreements contained herein required to
be complied with on or prior to the Closing Date.

          B.   No Litigation.  No action, suit, proceeding, writ, judgment,
injunction, decree or similar order of any governmental entity, authority or
agency or of any other third party restraining, enjoining or otherwise
preventing the consummation of any of the transactions contemplated by this
Agreement, or seeking to obtain any damages or any other relief as a result of
this Agreement or any of the transactions contemplated hereby, shall be pending
or threatened.
<PAGE>
 
                                                                               8

          C.  Approvals.  All governmental, corporate and other third party
filings, consents, authorizations and approvals (if any) that are required for
the consummation of the transactions contemplated hereby will have been duly
made and obtained in form and substance reasonably satisfactory to the Acquiror.

                                   SECTION VI

                                 MISCELLANEOUS
                                 -------------

          A.   Notices.  All notices, requests or instructions hereunder shall
be in writing and delivered personally, by telecopy or sent by registered or
certified mail, postage prepaid, as follows:

               (1)  if to the Acquiror or the Manager:

                    154 Pacific Highway
                    Greenwich NSW 2065
                    Australia
                    Telecopy:  (011) 61-2-906-5205

               (2)  if to the Seller:

                    One Poydras Plaza
                    639 Loyola Avenue
                    Suite 1700
                    New Orleans, Louisiana  70113
                    Attention:  President
                    Telecopy No.:  (504) 585-0500

Any of the above addresses may be changed at any time by notice given as
provided above; provided, however, that any such notice of change of address
shall be effective only upon receipt.  All notices, requests or instructions
given in accordance herewith shall be deemed received on the date of delivery,
if hand delivered or delivered by telecopy, and five days after the date of
mailing, if mailed.

          B.   Survival of Representations.  Each representation, warranty,
covenant and agreement of the parties hereto herein contained shall survive the
execution of this Agreement, notwithstanding any investigation at any time made
by or on behalf of any party hereto.

          C.   Entire Agreement.  This Agreement and the documents referred to
herein contain the entire agreement between the parties hereto with respect to
the transactions contemplated hereby, and amends and restates the Original
<PAGE>
 
                                                                               9

Agreement in its entirety.  No modification hereof shall be effective unless in
writing and signed by the party against which it is sought to be enforced.

          D.   Assignment.  This Agreement shall not be assignable by the Seller
or the Acquiror except pursuant to a writing executed by each of the parties
hereto; provided that the Acquiror may assign any of its rights hereunder to any
affiliate of the Acquiror which agrees to be bound by all of the obligations of
the Acquiror hereunder or to any lender in connection with any financing
transaction entered into by the Acquiror or any of its affiliates and that the
Manager hereby assigns its rights to acquire the Management Fee Shares to the
Acquiror.

          E.   Invalidity, Etc.  If any provision of this Agreement, or the
application of any such provision to any person or circumstance, shall be held
invalid by a court of competent jurisdiction, the remainder of this Agreement,
or the application of such provision to persons or circumstances other than
those as to which it is held invalid, shall not be affected thereby.

          F.   Expenses.  Except as expressly set forth herein, each of the
parties hereto shall bear such party's own expenses in connection with this
Agreement and the transactions contemplated hereby.

          G.   Headings.  The headings of this Agreement are for convenience of
reference only and are not part of the substance of this Agreement.

          H.   Binding Effect.  This Agreement shall be binding upon and inure
to the benefit of the parties hereto and their respective successors and
assigns.

          I.   Governing Law.  This Agreement shall be governed by and construed
in accordance with the laws of the State of Delaware applicable in the case of
agreements made and to be performed entirely within such State.

          J.   Counterparts.  This Agreement may be executed in counterparts,
each of which shall be deemed an original, but all of which taken together shall
constitute one and the same instrument.

          K.   Third Party Beneficiary.  This Agreement shall not create any
rights in favor of any person not a party hereto.

                              *        *        *
<PAGE>
 
                                                                              10

     IN WITNESS WHEREOF, this Agreement has been duly executed by the parties
hereto as of the date first above written.


                         PAUL RAMSAY HOLDINGS PTY. LIMITED



                         By /S/ Peter Evans
                           _________________________________
                           Name: Peter Evans
                           Title: Director

                         RAMSAY HEALTH CARE, INC.



                         By /S/ Reynold J. Jennings
                           _________________________________
                           Name: Reynold J. Jennings
                           Title: President


Solely for the purposes of
Sections I, III and VI:

RAMSAY HEALTH CARE PTY. LIMITED



By /S/ Peter Evans
  _________________________________
  Name: Peter Evans 
  Title: Director

<PAGE>
 
                                                                  EXHIBIT 10.102

     AMENDMENT dated as of October 3, 1995 (this "Amendment") made by Ramsay
Health Care, Inc., a Delaware corporation (the "Company"), to that certain
Rights Agreement dated as of August 1, 1995 (the "Agreement") between the
Company and First Union National Bank of North Carolina (the "Rights Agent").

     WHEREAS, the Company has determined (i) that the definition of "Beneficial
Owner" in the Agreement should be amended as provided herein, (ii) that the
definition of "Acquiring Person" in the Agreement should be amended to set forth
explicitly the status of shareholders who may inadvertently acquire 20% or more
of the Common Shares (as defined in the Agreement) and who are prepared to act
to correct such inadvertence, and (iii) the Agreement should be amended to
provide protection explicitly from coercive proxy and consent solicitations used
to circumvent the Agreement through a redemption of the Rights (as defined in
the Agreement) after a change in the Board of Directors;

     WHEREAS, the Company desires to provide certainty to its shareholders, the
securities markets and the Rights Agent in respect of the terms of the Agreement
and to further the purposes and intent of the Agreement; and

     WHEREAS, in order to effect the foregoing, the Company has determined to
amend the Agreement pursuant to Section 27 of the Agreement as set forth below.

     NOW, THEREFORE, effective as of the date hereof, the Agreement is hereby
amended pursuant to Section 27 thereof as follows:

          1.  Section 1(a) of the Agreement is hereby deleted and replaced with
     the following:

               "(a) "Acquiring Person" shall mean any Person (as such term is
          hereinafter defined) who or which, together with all Affiliates and
          Associates (as such terms are hereinafter defined) of such Person,
          shall be the Beneficial Owner (as such term is hereinafter defined) of
          20% or more of the Common Shares of the Company then outstanding, but
          shall not include the Company, any Subsidiary (as such term is
          hereinafter defined) of the Company, any employee benefit plan of the
          Company or any Subsidiary of the Company, or any Person holding Common
          Shares for or pursuant to the terms of any such plan.  Notwithstanding
          the foregoing, (i) no Person shall become an "Acquiring Person" solely
          as the result of (x) an acquisition after the date hereof of Common
          Shares by the Company which, by
<PAGE>
 
                                                                               2

          reducing the number of Common Shares outstanding, increases the
          proportionate number of shares beneficially owned by such Person to
          20% or more of the Common Shares of the Company then outstanding or
          (y) the acquisition of Beneficial Ownership of 20% or more of the
          Common Shares of the Company then outstanding in the good faith belief
          that such acquisition would not (A) cause such Beneficial Ownership to
          exceed 20% of the Common Shares then outstanding and such Person
          relied in good faith in computing the percentage of its Beneficial
          Ownership on publicly filed reports or documents of the Company which
          are inaccurate or out-of-date or (B) otherwise cause a Distribution
          Date to occur; (ii) subject to the proviso in this clause (ii), no
          Person (an "Acquiror") shall become an "Acquiring Person" as a result
          of the acquisition after the date hereof by an Acquiror from Paul J.
          Ramsay or from any Person who is an Affiliate or Associate of Paul J.
          Ramsay at the time of such acquisition (collectively, the "Ramsay
          Persons") of (1) any of the shares of Class B Preferred Stock
          currently held by any Ramsay Person, (2) any Common Shares issued
          pursuant to options or other rights to purchase Common Shares
          currently held by any Ramsay Person, (3) any Common Shares issued
          pursuant to the Class B Preferred Stock currently held by any Ramsay
          Person or (4) any Common Shares currently held by any Ramsay Person;
          provided that, at the time of such acquisition, the Acquiror (together
          with all of such Person's Affiliates and Associates) are not the
          Beneficial Owners of more than 1% or more of the Common Shares of the
          Company then outstanding and provided further that, following such
          acquisition, the Acquiror (together with all of such Person's
          Affiliates and Associates) do not become the Beneficial Owners of an
          additional 1% or more of the Common Shares of the Company then
          outstanding, and (iii) subject to the proviso in this clause (iii),
          none of the Ramsay Persons shall become an "Acquiring Person" in the
          event that any Ramsay Person (together with all other Ramsay Persons)
          become the Beneficial Owners after the date hereof of additional
          Common Shares; provided that the number of Common Shares of the
          Company of which all Ramsay Persons are the Beneficial Owners does not
          exceed one Common Share less than 50% of the Common Shares of the
          Company then outstanding.  Notwithstanding clause (i) of the prior
          sentence, if any Person that is not an Acquiring Person due to such
          clause (i) does not reduce its percentage
<PAGE>
 
                                                                               3

          of Beneficial Ownership of Common Shares to below 20% by 5:00 P.M. New
          York City time on the tenth Business Day after notice (including
          telephonic or facsimile) from the Company (the date of notice being
          the first day) that such Person's Beneficial Ownership of Common
          Shares so exceeds 20%, such Person shall, at the end of such ten
          Business Day period, become an Acquiring Person (and such clause (i)
          shall no longer apply to such Person).  For purposes of this
          definition, the determination whether any Person acted in "good faith"
          shall be conclusively determined by the Board of Directors of the
          Company, acting by a vote of those directors of the Company whose
          approval would be required to redeem the Rights under Section 23."

 
          2.  Section 1(c)(i) of the Agreement is hereby deleted and replaced
     with the following:

               "(i) which such Person or any of such Person's Affiliates or
          Associates is deemed to "beneficially own" within the meaning of Rule
          13d-3 under the Exchange Act, as in effect on the date of this
          Agreement;"

          3.  Section 23(a) of the Agreement is hereby deleted and replaced with
     the following:

               "(a)  The Board of Directors of the Company may, at its option,
          at any time prior to such time as a Person becomes an Acquiring
          Person, order the redemption of all, but not fewer than all, the then
          outstanding Rights at a redemption price of $.01 per Right,
          appropriately adjusted to reflect any stock split, stock dividend or
          similar transaction occurring after the date hereof (such redemption
          price being hereinafter referred to as the "Redemption Price, and the
          date of such redemption being the "Redemption Date"), and the Company,
          at its option, may pay the Redemption Price either in cash or Common
          Shares or other securities of the Company deemed by the Board of
          Directors of the Company, in the exercise of its sole discretion, to
          be at least equivalent in value to the Redemption Price; provided,
          however, that, in addition to any other limitations contained herein
          on the right to redeem outstanding Rights (including, without
          limitation, the occurrence of any event or the expiration of any
          period after which the Rights may no longer be redeemed), for the 120-
          day period after any date of a change (resulting from a proxy or
          consent
<PAGE>
 
                                                                               4

          solicitation) in a majority of the Board of Directors of the Company
          in office at the commencement of such solicitation, the Rights may
          only be redeemed if (A) there are directors then in office who were in
          office at the commencement of such solicitation and (B) the Board of
          Directors of the Company, with the concurrence of a majority of such
          directors then in office, determines that such redemption is, in their
          judgment, in the best interests of the Company and its stockholders."

          4.  This Amendment shall be deemed to be a contract made under the
     laws of the State of Delaware and for all purposes shall be governed by and
     construed in accordance with the laws of such State applicable to contracts
     made and to be performed entirely within such State, without regard to any
     conflict of laws principles which would apply the laws of any other
     jurisdiction.

          5.  Effective as of the date hereof, this Amendment supersedes that
     certain Interpretive Supplement dated as of September 1, 1995 made by the
     Company to the Agreement, and from and after the date hereof such
     Interpretive Supplement shall no longer be applicable.  The Agreement, as
     amended hereby, is hereby ratified, confirmed and continued in full force
     and effect.

          IN WITNESS WHEREOF, the Company has caused this Amendment to be
executed as of the date first above written.

                              RAMSAY HEALTH CARE, INC.


                              By /S/ Reynold J. Jennings
                                ____________________________
                                Name: Reynold J. Jennings
                                Title: President
<PAGE>
 
                                                                               5



          First Union National Bank of North Carolina hereby acknowledges
receipt of this Amendment made pursuant to Section 27 of the Agreement.

                              FIRST UNION NATIONAL BANK OF NORTH CAROLINA


                              By /S/ Melissa H. Sullivan
                                ____________________________
                                Name: Melissa H. Sullivan
                                Title: Account Executive

<PAGE>
 
                                                                      EXHIBIT 11
                   RAMSAY HEALTH CARE, INC. AND SUBSIDIARIES

                      COMPUTATION OF NET INCOME PER SHARE
                                  (UNAUDITED)

<TABLE>
<CAPTION>
 
 
                                                                       QUARTER ENDED
                                                                ---------------------------
                                                                        SEPTEMBER 30
                                                                ---------------------------
                                                                   1995             1994
                                                                ----------       ---------- 
<S>                                                             <C>              <C> 
PRIMARY
 Weighted average common shares outstanding...................   7,721,142        7,717,869
 Class A convertible preferred stock..........................         ---           22,910
 Class B convertible preferred stock, Series C................         ---*       1,424,860
 Net effect of dilutive stock options and warrants--based on                               
  the treasury stock method using average market price........         ---*         315,409
                                                                ----------       ----------
   TOTAL COMMON AND DILUTIVE                                                               
   COMMON EQUIVALENT SHARES...................................   7,721,142        9,481,048
                                                                ==========       ==========
                                                                                           
   Net Income (Loss) Available to Common Shareholders.........  $ (482,000)**    $  588,000
                                                                ==========       ==========
                                                                                           
   NET INCOME (LOSS) PER SHARE................................      $(0.06)           $0.06
                                                                ==========       ==========
                                                                                           
FULLY DILUTED                                                                              
 Weighted average common shares outstanding...................   7,735,328        7,720,043
 Class A convertible preferred stock..........................         ---           22,910
 Class B convertible preferred stock, Series C................         ---*       1,424,860
 Net effect of dilutive stock options and warrants--based on                               
  the treasury stock method using the year-end market                                      
  price, if higher than average market price..................         ---*         379,569
                                                                ----------       ----------
   TOTAL COMMON AND DILUTIVE                                                               
   COMMON EQUIVALENT SHARES...................................   7,735,328        9,547,382
                                                                ==========       ==========
                                                                                           
   Net Income (Loss) Available to Common Shareholders.........  $ (482,000)**    $  588,000
                                                                ==========       ========== 
 
   NET INCOME (LOSS) PER SHARE................................      $(0.06)            $0.06
                                                                    ======             =====

</TABLE>


*  Common stock equivalents not considered given loss reported for the period.

** Net loss reported for the period increased by dividends related to the
   Class B convertible preferred stock, Series C, totalling $91,000.

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1996
<PERIOD-START>                             JUL-01-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                       6,045,000
<SECURITIES>                                         0
<RECEIVABLES>                               27,174,000
<ALLOWANCES>                                 3,469,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                            40,867,000
<PP&E>                                     102,969,000
<DEPRECIATION>                              30,288,000
<TOTAL-ASSETS>                             136,129,000
<CURRENT-LIABILITIES>                       20,265,000
<BONDS>                                     52,178,000
<COMMON>                                        83,000
                                0
                                    233,000
<OTHER-SE>                                  61,071,000
<TOTAL-LIABILITY-AND-EQUITY>               136,129,000
<SALES>                                              0
<TOTAL-REVENUES>                            29,129,000
<CGS>                                                0
<TOTAL-COSTS>                               25,795,000
<OTHER-EXPENSES>                             1,283,000
<LOSS-PROVISION>                               956,000
<INTEREST-EXPENSE>                           1,726,000
<INCOME-PRETAX>                              (631,000)
<INCOME-TAX>                                 (240,000)
<INCOME-CONTINUING>                          (391,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (391,000)
<EPS-PRIMARY>                                  $(0.06)
<EPS-DILUTED>                                  $(0.06)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission